<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.1.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art510.dtd?><?SourceDTD.Version 5.1.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 2?><?origin publisher?><?FILEmeta_VETPAR6639 xml ?><?FILEmain xml ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Parasitol</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Parasitol</journal-id><journal-title-group><journal-title>Veterinary Parasitology</journal-title></journal-title-group><issn pub-type="ppub">0304-4017</issn><issn pub-type="epub">1873-2550</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3611597</article-id><article-id pub-id-type="publisher-id">S0304-4017(12)00680-2</article-id><article-id pub-id-type="doi">10.1016/j.vetpar.2012.12.032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Toxocara canis: Molecular basis of immune recognition and evasion </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maizels</surname><given-names>Rick M.</given-names></name><email>r.maizels@ed.ac.uk</email><xref rid="cor0005" ref-type="corresp">⁎</xref></contrib></contrib-group><aff>Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, West Mains Road, Edinburgh EH9 3JT, United Kingdom</aff><author-notes><corresp id="cor0005"><label>⁎</label>Tel.: +44 131 650 5511; fax: +44 131 650 5450. <email>r.maizels@ed.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>15</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>4</month><year>2013</year></pub-date><volume>193</volume><issue>4</issue><fpage>365</fpage><lpage>374</lpage><permissions><copyright-statement>© 2013 Elsevier B.V.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Elsevier B.V.</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">CC BY 3.0</ext-link> license</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Toxocara canis has extraordinary abilities to survive for many years in the tissues of diverse vertebrate species, as well as to develop to maturity in the intestinal tract of its definitive canid host. </plain></SENT>
<SENT sid="2" pm="."><plain>Human disease is caused by larval stages invading musculature, brain and the eye, and immune mechanisms appear to be ineffective at eliminating the infection. </plain></SENT>
<SENT sid="3" pm="."><plain>Survival of T. canis larvae can be attributed to two molecular strategies evolved by the parasite. </plain></SENT>
<SENT sid="4" pm="."><plain>Firstly, it releases quantities of ‘excretory–secretory’ products which include lectins, mucins and enzymes that interact with and modulate host immunity. </plain></SENT>
<SENT sid="5" pm="."><plain>For example, one lectin (CTL-1) is very similar to mammalian lectins, required for tissue inflammation, suggesting that T. canis may interfere with leucocyte extravasation into infected sites. </plain></SENT>
<SENT sid="6" pm="."><plain>The second strategy is the elaboration of a specialised mucin-rich surface coat; this is loosely attached to the parasite epicuticle in a fashion that permits rapid escape when host antibodies and cells adhere, resulting in an inflammatory reaction around a newly vacated focus. </plain></SENT>
<SENT sid="7" pm="."><plain>The mucins have been characterised as bearing multiple glycan side-chains, consisting of a blood-group-like trisaccharide with one or two O-methylation modifications. </plain></SENT>
<SENT sid="8" pm="."><plain>Both the lectins and these trisaccharides are targeted by host antibodies, with anti-lectin antibodies showing particular diagnostic promise. </plain></SENT>
<SENT sid="9" pm="."><plain>Antibodies to the mono-methylated trisaccharide appear to be T. canis-specific, as this epitope is not found in the closely related Toxocara cati, but all other antigenic determinants are very similar between the two species. </plain></SENT>
<SENT sid="10" pm="."><plain>This distinction may be important in designing new and more accurate diagnostic tests. </plain></SENT>
<SENT sid="11" pm="."><plain>Further tools to control toxocariasis could also arise from understanding the molecular cues and steps involved in larval development. In vitro-cultivated larvae express high levels of four mRNAs that are translationally silenced, as the proteins they encode are not detectable in cultured larvae. </plain></SENT>
<SENT sid="12" pm="."><plain>However, these appear to be produced once the parasite has entered the mammalian host, as they are recognised by specific antibodies in infected patients. </plain></SENT>
<SENT sid="13" pm="."><plain>Elucidating the function of these genes, or analysing if micro-RNA translational silencing suppresses production of the proteins, may point towards new drug targets for tissue-phase parasites in humans. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><title>Keywords</title><kwd>Antibodies</kwd><kwd>Diagnosis</kwd><kwd>Larva migrans</kwd><kwd>Mucins</kwd><kwd>Surface coat</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="sec0005"><label>1</label><title><text><SENT sid="14" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="15" pm="."><plain>Toxocara canis is the most prevalent intestinal roundworm of dogs, foxes and other canid species, with zoonotic potential for human beings. </plain></SENT>
<SENT sid="16" pm="."><plain>In many temperate countries, toxocariasis is the most common helminth infection and causes a significant morbidity (Despommier, 2003; Hotez and Wilkins, 2009; Rubinsky-Elefant et al., 2010; Smith et al., 2009). </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>The nematode has many salient biological features, which contribute to its continuing presence in animal and human populations. </plain></SENT>
<SENT sid="18" pm="."><plain>Firstly, it is able to invade an extraordinarily wide range of hosts, from invertebrates and poultry (Galvin, 1964) through to mice and man (Strube et al., 2013); for all but the definitive (canid) species, these represent intermediate hosts which can, through predation, allow the parasite to reach its final definitive host species. </plain></SENT>
<SENT sid="19" pm="."><plain>Secondly, the larval stage is able to enter a long-term developmental arrest, which allows it to suspend life cycle progression whilst in a paratenic host, and to resume maturation to the adult stage only once reaching a canid species. </plain></SENT>
<SENT sid="20" pm="."><plain>Thirdly, even in female canids, developmental arrest occurs so that larvae can dwell in tissues until pregnancy occurs, and then migrate transplacentally or via colostrum to infect the foetal or newborn pup (Schnieder et al., 2011). </plain></SENT>
</text></p><p><text><SENT sid="21" pm="."><plain>T. canis is highly prevalent in all canid populations that are not treated regularly with anthelmintics, and its infectivity to wild species renders elimination almost impossible. </plain></SENT>
<SENT sid="22" pm="."><plain>Furthermore, the arrested state has remarkable longevity: in experimentally infected monkeys for example, larvae remained viable in the tissues for 9 years and were able to infect mice on transfer (Beaver, 1962). </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Within the paratenic host, T. canis larvae can migrate widely including the liver, musculature and the central nervous system, causing the well-characterised syndrome of visceral larva migrans (VLM) (Beaver et al., 1952; Carvalho and Rocha, 2011; Schantz, 1989). </plain></SENT>
<SENT sid="24" pm="."><plain>The propensity to invade the brain and the eye has given rise to particular concern in the human population, with ocular toxocariasis (OT) a recognised syndrome (Good et al., 2004), and neurotoxocariasis (NT) inferred from cognitive deficits, higher prevalence among epilepsy cases (Quattrocchi et al., 2012), and finding larvae in post-mortem brain samples (Hill et al., 1985). </plain></SENT>
<SENT sid="25" pm="."><plain>Current options for treatment of humans infected with tissue-dwelling larvae are of uncertain efficacy because of the covert nature of the infection and the incomplete resolution of symptoms (Othman, 2012; Wiśniewska-Ligier et al., 2012). </plain></SENT>
</text></p></sec></SecTag><sec id="sec0010"><label>2</label><title><text><SENT sid="26" pm="."><plain>Immune recognition </plain></SENT>
</text></title><p><text><SENT sid="27" pm="."><plain>Pathogens are recognised initially by the innate immune system reacting to intrinsically foreign molecular signatures associated with xenogeneic species, such as bacterial lipopolysaccharide, unmethylated DNA and fungal carbohydrates. </plain></SENT>
<SENT sid="28" pm="."><plain>Such signals are essential for innate immune sentinel cells, such as dendritic cells, to react to the presence of infectious organisms and to initiate pathogen-specific responses from the adaptive immune system. </plain></SENT>
<SENT sid="29" pm="."><plain>Currently, few such “pathogen-associated molecular patterns” (PAMPs) have been defined for any helminth parasite, but their existence in T. canis can be surmised by the strong adaptive immune response that occurs in this infection. </plain></SENT>
<SENT sid="30" pm="."><plain>The major feature of this adaptive immune response is production of T. canis-specific antibodies, associated with CD4+ T-helper type 2 cell (Th2) activity (Del Prete et al., 1991). </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>Such a Th2 response is characterised by release of a specific subset of mediators, in particular the type 2 cytokines IL-4, -5, -10 and -13, during infection. </plain></SENT>
<SENT sid="32" pm="."><plain>Subsequently, IL-4 promotes B cell differentiation and antibody class-switching, while IL-5 drives the differentiation of eosinophils, a marked feature of human Toxocara spp. infection (Beaver et al., 1952). </plain></SENT>
<SENT sid="33" pm="."><plain>T cell responses to T. canis in human beings are clearly of the Th2 type, and are stimulated by the “excretory–secretory” (ES) antigens of the parasite (Del Prete et al., 1991). </plain></SENT>
<SENT sid="34" pm="."><plain>However, no individual T cell specific antigen or epitope has yet been defined from T. canis. </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>Recently, the distinction between innate and adaptive arms of immunity has become much more blurred with identification of innate lymphoid cells, which can rapidly produce Type-2 cytokines (Neill et al., 2010) without requiring activation by dendritic cells (Smith et al., 2012). </plain></SENT>
<SENT sid="36" pm="."><plain>Indeed, it has been known for some time that some innate populations of cells can participate in the “Th2 response” to T. canis, for example non-B-non-T cells produce IL-5, even in T cell-deficient nude mice infected with the parasite (Takamoto et al., 1995). </plain></SENT>
<SENT sid="37" pm="."><plain>Moreover, eosinophilia in infected mice shows a biphasic response with early (day 10) and late (day 21) peaks; while the later peak is absent in CD4+ T cell-deficient mice, the earlier one is intact, indicating that it is generated by the innate rather than the adaptive Type-2 response (Takamoto et al., 1998). </plain></SENT>
</text></p><p><text><SENT sid="38" pm="."><plain>Generation of specific antibodies provides the most definitive evidence for infection and is the basis for all diagnostic tests for toxocariasis; with ELISA and Western blot reactivity to T. canis ES (TES) antigens generally employed. </plain></SENT>
<SENT sid="39" pm="."><plain>However, the diagnostic field is still evolving with respect to the optimal target antigens that should be used, and more critically to the interpretation of antibody reactivity to an infection which is frequently covert and in which symptoms do not necessarily correlate with infection intensity or antibody titre (Smith et al., 2009). </plain></SENT>
</text></p><p><text><SENT sid="40" pm="."><plain>There are now extensive data on the seroprevalence of anti-TES antibodies in human populations around the world, using the established ELISA. </plain></SENT>
<SENT sid="41" pm="."><plain>In older studies, seropositivity in Europe ranged from 3 to 7% in adults and 7 to 23% in children (Gillespie et al., 1993), while in the USA 13.9% of those over 6 years of age were antibody-positive (Won et al., 2008). </plain></SENT>
<SENT sid="42" pm="."><plain>Remarkably, seroprevalences exceeded 50% in tropical settings such as the Caribbean (Bundy et al., 1987; Magnaval et al., 1994). </plain></SENT>
<SENT sid="43" pm="."><plain>More recent studies similarly report seroprevalences of 14.5% in Polish teenagers (Jarosz et al., 2010), 13% in Turkish children (Doğan et al., 2007) and 9% in Iranian under-10s (Fallah et al., 2007), rising to 27% in Brazilian Amazonia (Rubinsky-Elefant et al., 2008) and 45–82% in different rural districts of Sulawesi, Indonesia (Hayashi et al., 2005). </plain></SENT>
<SENT sid="44" pm="."><plain>Hence widespread toxocariasis remains of great concern in most parts of the world. </plain></SENT>
</text></p><p><text><SENT sid="45" pm="."><plain>The question of which serum antibody isotypes are most relevant still remains to be explored. </plain></SENT>
<SENT sid="46" pm="."><plain>Most human infections generate antibodies of the IgG1 subclass, with significant levels of both IgM and IgE (Smith, 1993). </plain></SENT>
<SENT sid="47" pm="."><plain>The IgG4 isotype, which can be predominant in other, more intense, tissue helminth infections such as filariasis and schistosomiasis (Maizels et al., 1995) is less prominent, although reportedly more evident in active cases of visceral larva migrans (Obwaller et al., 1998). </plain></SENT>
<SENT sid="48" pm="."><plain>An unresolved issue is whether the expression of IgE correlates with active infection and/or invasion of certain tissue sites in the host, or possibly mediates only bystander allergic-type reactions such as infection-related rashes (Magnaval et al., 2006). </plain></SENT>
<SENT sid="49" pm="."><plain>Related to this question is whether particular isotypes are functionally important in tissue immunity, for example by trapping larvae or activating Fc-dependent protection mechanisms. </plain></SENT>
</text></p><p><text><SENT sid="50" pm="."><plain>Recent analyses of differential expression profiles of anti-Toxocara spp. antibody isotypes, studying children receiving thiabendazole therapy, found that specific IgE and eosinophilia declined within the first year, with IgA and IgG4 falling at later times (Elefant et al., 2006). </plain></SENT>
<SENT sid="51" pm="."><plain>Such information may prove useful in addressing the need for new immunological markers that could be used to chart the success of therapy in drug-treated patients. </plain></SENT>
</text></p></sec><sec id="sec0015"><label>3</label><title><text><SENT sid="52" pm="."><plain>Immunity in the definitive host </plain></SENT>
</text></title><p><text><SENT sid="53" pm="."><plain>Although almost all immunological studies on T. canis have centred a round the tissue-migrating larvae, the immune response of the final canid host to intestinal adult worms is also of central importance. </plain></SENT>
<SENT sid="54" pm="."><plain>A long-term aim of research in this area is to develop an effective vaccine against canine toxocariasis, which ideally would build immunity to both tissue- and intestinal stages of the parasite. </plain></SENT>
</text></p><p><text><SENT sid="55" pm="."><plain>Intestinal immunity to ascarid worms is poorly understood; taking a comparative approach, based on animal models of taxonomically distant nematodes (e.g. Nippostrongylus brasiliensis, Trichuris muris), it would be predicted that Th2-dependent mechanisms act to expel the parasites, but the cell types and molecular mediators participating in expulsion are as yet unknown. </plain></SENT>
<SENT sid="56" pm="."><plain>Notably, it has been reported that Foxp3+ regulatory T cells are more numerous in dogs with intestinal nematode infections (Junginger et al., 2012), suggesting that mucosal tolerance is involved in persistence of infection. </plain></SENT>
<SENT sid="57" pm="."><plain>Thus, interventional strategies to neutralise Tregs could promote protective immunity, as has been reported in some animal models of helminth infection (Taylor et al., 2007). </plain></SENT>
</text></p><p><text><SENT sid="58" pm="."><plain>Immunity to the larval stage is similarly poorly understood, although important not only to the definitive canid hosts, but also in the human setting. </plain></SENT>
<SENT sid="59" pm="."><plain>To date, attempts to generate protective anti-larval immunity in laboratory rodents have had mixed results. </plain></SENT>
<SENT sid="60" pm="."><plain>While an early report noted that immunisation with somatic extracts of eggs or adult worms resulted in approximately half the number of surviving challenge larvae (Izzat and Olson, 1970), susceptibility to larval infection was unaltered in mice immunised with UV-irradiated eggs or larval ES antigens (Abo-Shehada et al., 1991). </plain></SENT>
<SENT sid="61" pm="."><plain>Likewise, a more recent study found no evidence of protection by administering a second challenge of larvae to previously infected mice, other than they were more likely to sequester in the brain (Kolbeková et al., 2011). </plain></SENT>
<SENT sid="62" pm="."><plain>A more systematic approach, comparing immunisation and adjuvant regimes and following more closely the resultant immune response, would help clarify this question. </plain></SENT>
</text></p></sec><sec id="sec0020"><label>4</label><title><text><SENT sid="63" pm="."><plain>Toxocara spp. and allergy </plain></SENT>
</text></title><p><text><SENT sid="64" pm="."><plain>Many, but not all, studies have linked human Toxocara spp. infection with exacerbation of allergic disease (reviewed by Pinelli and Aranzamendi (2012)). </plain></SENT>
<SENT sid="65" pm="."><plain>Children with T. canis seroreactivity have been reported to show more pronounced IgE and eosinophilia than seronegative individuals as well as greater propensity for airway allergic symptoms such as asthma (Buijs et al., 1997) and allergic rhinitis (Yariktas et al., 2007). </plain></SENT>
<SENT sid="66" pm="."><plain>Mice infected with T. canis developed compromised lung function for up to 60 days, associated with bronchioalveolar eosinophilia and serum IgE production (Pinelli et al., 2005). </plain></SENT>
<SENT sid="67" pm="."><plain>Moreover, using a protocol in mice which induces an airway allergic response to the model antigen ovalbumin, T. canis infection prior to ovalbumin challenge was found to exacerbate lung pathology (Pinelli et al., 2008). </plain></SENT>
</text></p><p><text><SENT sid="68" pm="."><plain>On a broader scale, infection with T. canis might predispose human beings towards development of asthma (Cooper, 2008). </plain></SENT>
<SENT sid="69" pm="."><plain>Such pro-allergic effects seemingly run counter to a recent interpretation of the “hygiene hypothesis”, which suggests that parasitic helminths dampen allergies and other immunopathologies through their general immune suppressive properties (Maizels, 2005). </plain></SENT>
<SENT sid="70" pm="."><plain>However, it is important to recognise that T. canis is adapted to its definitive host rather than to intermediate or accidental hosts such as the human, and in the maladapted setting, the host may react more vigorously and pathologically. </plain></SENT>
</text></p></sec><sec id="sec0025"><label>5</label><title><text><SENT sid="71" pm="."><plain>Evasion of the immune response </plain></SENT>
</text></title><p><text><SENT sid="72" pm="."><plain>Long-term survival of parasitic helminths in the host is an impressive feat in the face of the well-armed immune response, which mobilises multiple cell types and molecular mediators, including high-affinity antibodies, to attack invading organisms. T. canis larvae invade from the host intestinal tract and disseminate throughout the tissues of the body, remaining in an extracellular state, generating little inflammatory reaction at the site of infection. </plain></SENT>
<SENT sid="73" pm="."><plain>Therefore, it is implicit that T. canis is able to disable host effector mechanisms in an extremely effective fashion. </plain></SENT>
</text></p><p><text><SENT sid="74" pm="."><plain>One cell type, associated with immunity to helminths in the tissues, is the eosinophil (Klion and Nutman, 2004; Maizels and Balic, 2004), which is able to exgorge noxious products such as major basic protein, as well as generate superoxides (through eosinophil peroxidase) and other damaging free radicals. </plain></SENT>
<SENT sid="75" pm="."><plain>Although eosinophilia is certainly a prominent feature of toxocariasis, as indeed in many other helminth infections, it appears that T. canis is largely resistant to attack by this cell type. </plain></SENT>
<SENT sid="76" pm="."><plain>In mice over-expressing an IL-5 transgene (IL-5T) and with resultant hypereosinophilia, T. canis larvae are unharmed, although an unrelated helminth N. brasiliensis is eliminated (Dent et al., 1999). </plain></SENT>
<SENT sid="77" pm="."><plain>Notably, when N. brasiliensis is introduced to IL-5T mice in the presence of T. canis ES antigens (see below), their survival is greatly enhanced (Giacomin et al., 2008). </plain></SENT>
<SENT sid="78" pm="."><plain>Conversely, in IL-5-deficient mice there is no change in larval survival, although pathology in the lung is diminished compared to wild-type (IL-5-sufficient) controls (Takamoto et al., 1997). </plain></SENT>
</text></p></sec><sec id="sec0030"><label>6</label><title><text><SENT sid="79" pm="."><plain>Shedding of the surface coat </plain></SENT>
</text></title><p><text><SENT sid="80" pm="."><plain>The inability of eosinophils to kill T. canis was observed in vitro, in experiments in which cells and larvae are co-incubated. </plain></SENT>
<SENT sid="81" pm="."><plain>While in the presence of specific antibodies, eosinophils rapidly adhered to the parasite surface, but within 24 h the larvae had escaped from surrounding cells (Fattah et al., 1986), leaving the eosinophils still attached to material which had clearly become detached from the surface (Badley et al., 1987a). </plain></SENT>
</text></p><p><text><SENT sid="82" pm="."><plain>These observations of shedding cells bound to the parasite surface have an interesting link to electron microscopic observations of a labile surface coat from the larval parasite, distal to and separated from the nematode cuticle. </plain></SENT>
<SENT sid="83" pm="."><plain>When larvae are treated with a lipophilic stain, a “fuzzy coat” can be visualised, 10–20 nm thick and lying approximately the same distance from the cuticle surface, while following each cuticle annulation and fold (Page et al., 1992b). </plain></SENT>
<SENT sid="84" pm="."><plain>The fuzzy coat can be stained with polycationic ligands such as ferritin, indicating that it bears an overall negative charge. </plain></SENT>
<SENT sid="85" pm="."><plain>Notably, the coat is lost within 2 h of co-incubating larvae with antibodies reactive to the surface, elucidating the physical basis of the original report of antibody shedding by T. canis larvae in vitro (Smith et al., 1981). </plain></SENT>
</text></p><p><text><SENT sid="86" pm="."><plain>While the first observations of antibody shedding employed polyclonal sera, later studies confirmed this with monoclonal antibody (MAb) reagents. </plain></SENT>
<SENT sid="87" pm="."><plain>In particular, two MAbs designated Tcn-2 and Tcn-8, which bind strongly to live larvae, and which are rapidly shed, were also demonstrated by immuno-electron microscopy to bind the surface coat (Page et al., 1992b). </plain></SENT>
<SENT sid="88" pm="."><plain>Interestingly, the same antibodies were used to stain sections of larvae, and identified two distinct secretory bodies within the larva, the oesophageal gland opening into the buccal cavity, and the mid-body secretory column which is a ducted secretory pore (Page et al., 1992a). </plain></SENT>
</text></p><p><text><SENT sid="89" pm="."><plain>The Tcn-2 and Tcn-8 monoclonal antibodies which bind the surface coat, recognise related but distinct trisaccharide glycan side-chains (Schabussova et al., 2007), which are expressed on the family of mucin polypeptides, principally MUC-1, -2 and -3 collectively termed TES-120 (Loukas et al., 2000b). </plain></SENT>
<SENT sid="90" pm="."><plain>The coat and the secretory column are also bound by the N-acetylglucosamine-specific lectin, Wheat Germ Agglutinin (Page et al., 1992c). </plain></SENT>
<SENT sid="91" pm="."><plain>While the fuzzy coat therefore seems likely to represent a mucin- and glycan-rich assembly, it is not yet determined if the mucins are further covalently modified in any way, or linked to other molecular components, in order to form a stable coat structure. </plain></SENT>
</text></p></sec><sec id="sec0035"><label>7</label><title><text><SENT sid="92" pm="."><plain>TES antigens and immune modulation by TES antigens </plain></SENT>
</text></title><p><text><SENT sid="93" pm="."><plain>While the ability of larvae to escape antibody and cellular attack is unusual among helminth parasites, a more general feature is modulation of the systemic immune response to infection. </plain></SENT>
<SENT sid="94" pm="."><plain>In T. canis infected mice, the pro-inflammatory responses of macrophages are dampened (Kuroda et al., 2001), while susceptibility to a sub-lethal dose of Japanese encephalitis virus is increased (Gupta and Pavri, 1987). </plain></SENT>
<SENT sid="95" pm="."><plain>Recent work has reported an expansion of the suppressive T cell subset of Foxp3+ regulatory T cells in murine toxocariasis (Othman et al., 2011), which may underpin some of these in vivo effects. </plain></SENT>
</text></p><p><text><SENT sid="96" pm="."><plain>It is likely that both local and systemic effects of parasite infection on host immunity are mediated by secreted products, such as the TES antigens. </plain></SENT>
<SENT sid="97" pm="."><plain>As mentioned previously, TES can inhibit the protective effects of eosinophils (Giacomin et al., 2008) and is able to induce recruitment of both eosinophils (Sugane and Oshima, 1984) and alternatively activated macrophages (Allen and MacDonald, 1998). </plain></SENT>
<SENT sid="98" pm="."><plain>However, TES is a complex mixture of differing molecular components, which require further characterisation if the specific immunomodulatory effects of the parasite are to be understood. </plain></SENT>
</text></p><p><text><SENT sid="99" pm="."><plain>de Savigny (1975) first reported that T. canis larvae show remarkable longevity in vitro, allowing long-term collection of ES antigens over many months. </plain></SENT>
<SENT sid="100" pm="."><plain>As detailed below, such “TES” proved to be extremely useful for diagnostic purposes. </plain></SENT>
<SENT sid="101" pm="."><plain>Within TES, the molecular components were first described by their molecular weight on SDS-PAGE analysis, with major bands evident at 26, 32, 45, 55, 70, 120 and 400 kDa (Maizels et al., 1984); even at this stage the extensive overlap between surface proteins and those in TES was clear. </plain></SENT>
</text></p><p><text><SENT sid="102" pm="."><plain>Subsequent studies of TES used 1- and 2-dimensional SDS-PAGE to more precisely classify components (Badley et al., 1987b; Meghji and Maizels, 1986), together with techniques such as biosynthetic labelling with radioactive amino acids (Page and Maizels, 1992; Sugane et al., 1985). </plain></SENT>
<SENT sid="103" pm="."><plain>A high degree of glycosylation was observed, amounting to ∼40% of TES by weight (Meghji and Maizels, 1986). </plain></SENT>
<SENT sid="104" pm="."><plain>Histological sections of liver from infected mice also showed that TES is released from larvae in vivo (Parsons et al., 1986). </plain></SENT>
</text></p><p><text><SENT sid="105" pm="."><plain>Over subsequent years, a combination of peptide sequencing (Loukas et al., 1999b), monoclonal antibody binding (Bowman et al., 1993; Maizels et al., 1987) and recombinant DNA techniques (Gems et al., 1995; Gems and Maizels, 1996; Maizels et al., 2000) has characterised three sets of TES proteins and glycoproteins (TES-26, -32/70 and -120) while the other components remain to be fully characterised. </plain></SENT>
</text></p><sec id="sec0040"><label>7.1</label><title><text><SENT sid="106" pm="."><plain>TES-26: Tc-PEB-1 </plain></SENT>
</text></title><p><text><SENT sid="107" pm="."><plain>TES-26 is a homologue of mammalian phosphatidylethanolamine (PE)-binding protein and was renamed Tc-PEB-1. </plain></SENT>
<SENT sid="108" pm="."><plain>It was identified initially from an abundant mRNA bearing at its 5′ end the conserved a nematode 22-nt spliced leader (SL1) sequence found previously in Caenorhabditis elegans (Krause and Hirsh, 1987). </plain></SENT>
<SENT sid="109" pm="."><plain>While the T. canis PEB protein is similar to homologues from other species in functionally binding PE, its structure differs markedly in including a 72-aa N-terminal extension, containing a tandemly repeated six-cysteine motif homologous to the potassium channel toxin of the sea anemone, Stocihactis helianthus (Gems et al., 1995). </plain></SENT>
<SENT sid="110" pm="."><plain>The S. helianthus K-toxin (ShKT) domain figures prominently in a number of other secreted proteins not only from Toxocara spp., but also from other nematode parasites, although as yet has no known functional role. </plain></SENT>
</text></p></sec><sec id="sec0045"><label>7.2</label><title><text><SENT sid="111" pm="."><plain>TES-32 and -70: C-type lectins (CTLs) </plain></SENT>
</text></title><p><text><SENT sid="112" pm="."><plain>TES-32 (Loukas et al., 1999b) and TES-70 (Loukas et al., 2000a) were isolated by matching tryptic peptide sequences from gel-purified proteins to an EST database of larval mRNA sequences (Tetteh et al., 1999). </plain></SENT>
<SENT sid="113" pm="."><plain>Both are members of the C-type lectin family; hence TES-32 was reassigned at Tc-CTL-1. </plain></SENT>
<SENT sid="114" pm="."><plain>This is homologous to mammalian mannose-binding protein, and modelling studies which indicated that Tc-CTL-1 does indeed bind mannose residues were experimentally confirmed (Loukas et al., 1999b). </plain></SENT>
<SENT sid="115" pm="."><plain>Within the EST database were two related sequences with minor amino acid variants which have been designated Tc-CTL-2 and -3. </plain></SENT>
<SENT sid="116" pm="."><plain>A near-identical sequence was later described by an independent group as a proteoglycan core protein (Yamasaki et al., 1998). </plain></SENT>
</text></p><p><text><SENT sid="117" pm="."><plain>Tc-CTL-1 is also one of the major larval surface proteins, and monoclonal antibody localisation has shown that it is expressed in the cuticle of the parasite (Page et al., 1992a). </plain></SENT>
<SENT sid="118" pm="."><plain>Whether the cuticular form bears any modification, and/or is secreted directly from the cuticle into the larval environment, remains to be determined. </plain></SENT>
<SENT sid="119" pm="."><plain>Tc-CTL-1 also appears to be well-conserved within the Toxocara genus; the anti-Tc-CTL-1 Mab Tcn-3 reacts with proteins in both Toxocara cati (Kennedy et al., 1987) and Toxocara vitulorum (Page et al., 1991), albeit of differing molecular weights. </plain></SENT>
<SENT sid="120" pm="."><plain>In addition, there is significant cross-reactivity of Tc-CTL-1 with antibodies generated to the raccoon ascarid Baylisascaris procyonis (Boyce et al., 1988). </plain></SENT>
<SENT sid="121" pm="."><plain>However, there is no cross-reaction with ES from Toxascaris leonina (Page et al., 1991) and mice infected with Ascaris suum do not develop serum antibodies to Tc-CTL-1. </plain></SENT>
</text></p><p><text><SENT sid="122" pm="."><plain>TES-70 is a further C-type lectin, now referred to as Tc-CTL-4, which has been shown to bind to canine cells in vitro. </plain></SENT>
<SENT sid="123" pm="."><plain>Although the mammalian ligand has yet to be identified, this is the first instance of a TES product directly targeting host receptors (Loukas et al., 2000a). </plain></SENT>
<SENT sid="124" pm="."><plain>Monoclonal antibodies to Tc-CTL-4 also react with products in ES of other Toxocara species, indicating that secretion of C-type lectins might be a shared hallmark of this genus (Page et al., 1991). </plain></SENT>
</text></p></sec><sec id="sec0050"><label>7.3</label><title><text><SENT sid="125" pm="."><plain>TES-120: mucins </plain></SENT>
</text></title><p><text><SENT sid="126" pm="."><plain>As with TES-26, the original isolation of cDNA clones corresponding to TES-120 antigens was facilitated by the presence of the SL1 trans-spliced leader sequence. </plain></SENT>
<SENT sid="127" pm="."><plain>The conserved sequence of the SL1 permitted full-length cloning, without the requirement for a cDNA library or development of specific probes (Gems and Maizels, 1996). </plain></SENT>
<SENT sid="128" pm="."><plain>The most highly expressed gene encoded a mucin sequence, designated MUC-1. </plain></SENT>
<SENT sid="129" pm="."><plain>Further studies established that T. canis larvae express a set of mucin-like glycoproteins with extensive Serine-Threonine rich domains which act as sites of O-linked glycosylation, forming a surface “fuzzy coat” described previously (Page et al., 1992b). </plain></SENT>
<SENT sid="130" pm="."><plain>The principal mucins are MUC-1 (Gems and Maizels, 1996), -2 and -3 (Loukas et al., 2000b) with less abundant components MUC-4 and -5 (Doedens et al., 2001), differing in structure and the relative proportions of Serine or Threonine residues (Loukas et al., 2000b). </plain></SENT>
<SENT sid="131" pm="."><plain>Most strikingly, all contain tandemly repeated ShKT domains at either or both of the N- and C-terminal regions, flanking the central mucin core. </plain></SENT>
</text></p></sec></sec><sec id="sec0055"><label>8</label><title><text><SENT sid="132" pm="."><plain>Glycans of T. canis </plain></SENT>
</text></title><p><text><SENT sid="133" pm="."><plain>Initial chemical analysis of TES revealed a high content of galactose and N-acetylgalactosamine, amounting to ∼40% by total weight of the secreted products (Meghji and Maizels, 1986). </plain></SENT>
<SENT sid="134" pm="."><plain>However, there is only a limited degree of N-glycoslyation, of CTL-1 and -4, as revealed by molecular weight shifts following N-glycanase digestion of total TES products. </plain></SENT>
<SENT sid="135" pm="."><plain>In contrast, O-linked sugars represent the majority of the released carbohydrates, mostly linked to the mucin families (MUC-1 to -5). </plain></SENT>
</text></p><p><text><SENT sid="136" pm="."><plain>Mass spectrometry of the O-linked sugars determined them to be two related trisaccharides, 2-O-Me-Fucα1-2(4-O-Me)Galβ1-3-GalNAc, and 2-O-Me-Fucα1-2Galβ1-3GalNAc, differing only in whether the central galactose sugar bears an O-methyl side chain (Khoo et al., 1991). </plain></SENT>
<SENT sid="137" pm="."><plain>Notably, the non-O-methylated form of this trisaccharide is identical to the human blood group H antigen, providing a structural explanation for the expression of blood group specificities by T. canis (Smith et al., 1983). </plain></SENT>
<SENT sid="138" pm="."><plain>Chemical synthesis of the Toxocara spp.-specific glycan structures (Amer et al., 2001) provided material for ELISA with monoclonal antibodies and human sera (Schabussova et al., 2007). </plain></SENT>
<SENT sid="139" pm="."><plain>This confirmed that the species-specific Mab, Tcn-2, recognises the mono-methylated trisaccharide, while the shared epitope present in other Toxocara species is the dimethylated structure (Schabussova et al., 2007). </plain></SENT>
</text></p><p><text><SENT sid="140" pm="."><plain>Subsequently, synthesis of the glycan Fucα1-2Galβ1-3GalNAc, omitting methylation of either the terminal fucose or the intermediate galactose, was used to demonstrate loss of antibody binding, formally confirming that the Me-Gal residue is essential for this reaction (Koizumi et al., 2012). </plain></SENT>
<SENT sid="141" pm="."><plain>In addition, analysis of the N-linked glycan species in TES antigens has been undertaken, identifying a dominant and relatively simple biantennary Man2Man-GlcNAc-GlcNAc side chain (Khoo et al., 1993). </plain></SENT>
</text></p></sec><SecTag type="RESULTS"><sec id="sec0060"><label>9</label><title><text><SENT sid="142" pm="."><plain>Immuno-diagnosis </plain></SENT>
</text></title><p><text><SENT sid="143" pm="."><plain>The original reports from De Savigny (de Savigny and Tizard, 1977; de Savigny et al., 1979) provided a breakthrough for immuno-diagnosis of toxocariasis, as the sensitivity and specificity of TES in assays such as ELISA and Western Blot proved to be far superior to use of whole worm extracts (Van Knapen et al., 1983). </plain></SENT>
<SENT sid="144" pm="."><plain>Indeed, the use of TES has been successfully translated into a commercial diagnostic kit (Jacquier et al., 1991). </plain></SENT>
<SENT sid="145" pm="."><plain>Nevertheless, the sensitivity and specificity of TES-based immunodiagnostic tests vary around the 90% level, and there are concerns that the presence of blood group-like or other cross-reactive carbohydrates could be responsible for a number of false-positive results (Smith et al., 1984, 2009). </plain></SENT>
<SENT sid="146" pm="."><plain>The blood group-like antigens are more abundant on higher molecular-weight TES components (TES-120 and TES-400), and therefore a Western blotting procedure to assay human antibodies to the lower molecular weight TES components (TES-26 and TES-32) has also been developed (Magnaval et al., 1991, 2002). </plain></SENT>
</text></p><p><text><SENT sid="147" pm="."><plain>Recombinant proteins are now being developed for detection of specific antibodies for toxocariasis. </plain></SENT>
<SENT sid="148" pm="."><plain>The TES-32 protein (which corresponds to the C-type lectin CTL-1 (Loukas et al., 1999b)) was shown to be detected by serum antibodies from all 9 toxocariasis patients tested. </plain></SENT>
<SENT sid="149" pm="."><plain>In addition, sera from animals carrying T. cati infection were also reactive, reflecting the cross-reactivity of this protein between Toxocara species (Kennedy et al., 1987). </plain></SENT>
<SENT sid="150" pm="."><plain>In a standard ELISA assay, some 43% of sera from other helminth infections cross-reacted with whole TES, but this was reduced to 2% when tested against recombinant CTL-1 adsorbed at an optimal antigen concentration (Yamasaki et al., 2000). </plain></SENT>
<SENT sid="151" pm="."><plain>In a subsequent evaluation, sera from 26/215 (12%) of children from Pernambuco, Brazil, recognised Tc-CTL-1 (TES-32) (De Andrade Lima Coêlho et al., 2005). </plain></SENT>
<SENT sid="152" pm="."><plain>It should be noted that in both studies, recombinant Tc-CTL-1 was produced as inclusion bodies in bacteria and required 8 M urea solubilisation, indicating that a correctly folded version of the same antigen may show increased immunoreactivity as this would detect conformational as well as linear epitopes. </plain></SENT>
</text></p><p><text><SENT sid="153" pm="."><plain>Most diagnostic serological tests measure total IgG antibodies. </plain></SENT>
<SENT sid="154" pm="."><plain>In a comparative study to test an IgG4-specific assay, it was noted that sensitivity was markedly reduced (as many patients do not mount an IgG4 response) but specificity was greatly enhanced compared to measuring total IgG (Noordin et al., 2005). </plain></SENT>
<SENT sid="155" pm="."><plain>These authors went on to develop an IgG4-specific diagnostic assay employing three recombinant antigens (Tc-PEB-1 or TES-26, Tc-CTL-1 or TES-32 also named TES-30USM, and Tc-MUC-1 or TES120). </plain></SENT>
<SENT sid="156" pm="."><plain>While none of the antigens individually showed 100% specificity, a combination of the three was able to detect all samples serologically reactive to native TES, and showed cross-reactivity with only 2–4% of serum samples from other infections (Mohamad et al., 2009). </plain></SENT>
</text></p><p><text><SENT sid="157" pm="."><plain>As well as recombinant proteins, the specific glycan structures associated with T. canis also hold promise for immuno-diagnosis. </plain></SENT>
<SENT sid="158" pm="."><plain>It was found that sera from human toxocariasis patients reacted to the di-O-methylated structure 2-O-Me-Fucα1-2(4-O-Me)Galβ1-3-GalNAc, although no antibodies were detected to the species-specific monomethylated form Schabussova et al. (2007). </plain></SENT>
<SENT sid="159" pm="."><plain>As is often the case with glycan epitopes, human antibodies were restricted to the IgM and IgG2 isotypes. </plain></SENT>
</text></p><p><text><SENT sid="160" pm="."><plain>Using polyclonal antibodies against TES in a sandwich ELISA, circulating parasite antigens can be detected in the serum of infected dogs, particularly pups (Matsumura et al., 1984), and in serum of children with suspected infection (Luo et al., 1999). </plain></SENT>
<SENT sid="161" pm="."><plain>Similarly, circulating antigen could be found in both human and experimental mouse serum samples, with the monoclonal antibody Tcn-2 which recognises a species-specific repetitive epitope that facilitates detection (Gillespie et al., 1993; Robertson et al., 1988). </plain></SENT>
</text></p></sec></SecTag><sec id="sec0065"><label>10</label><title><text><SENT sid="162" pm="."><plain>Genomics, transcriptomics and other molecular analyses </plain></SENT>
</text></title><p><text><SENT sid="163" pm="."><plain>Despite the importance of T. canis in both veterinary and zoonotic contexts, there is relatively little information available at the genomic and transcriptomic levels. </plain></SENT>
<SENT sid="164" pm="."><plain>Currently, the parasite genome has yet to be sequenced. </plain></SENT>
<SENT sid="165" pm="."><plain>However, the 14,162-bp mitochondrial sequence has been published (Jex et al., 2008), and the 273-Mb genome sequence of the related parasite A. suum was recently reported (Jex et al., 2011). </plain></SENT>
</text></p><p><text><SENT sid="166" pm="."><plain>Similarly, the T. canis transcriptome is relatively under-explored (Gasser, 2013). </plain></SENT>
<SENT sid="167" pm="."><plain>Over 10 years ago a small-scale EST project on larval cDNAs was able to identify 128 distinct genes and despite its limited scope, this study characterised most of the major secreted antigens and a number of novel gene families, many of which are listed in Table 1 (Tetteh et al., 1999). </plain></SENT>
<SENT sid="168" pm="."><plain>A further 1975 gene clusters were assembled from ∼5000 Sanger sequencing reads and can be searched at <ext-link ext-link-type="uri" xlink:href="http://nematode.net/">http://nematode.net</ext-link>. </plain></SENT>
<SENT sid="169" pm="."><plain>More recently, a female adult cDNA sequencing effort yielded 79 genes, including 2 C-type lectins and an As16 homologue (Zhou et al., 2011). </plain></SENT>
<SENT sid="170" pm="."><plain>However, most of the identified genes have yet to be annotated or deposited in public databases, with NCBI for example holding only 28 distinct non-mitochondrial/ribosomal protein gene sequences at the time of writing. </plain></SENT>
<SENT sid="171" pm="."><plain>Much more ambitious datasets are required to establish the protein repertoire of T. canis and to identify patterns of stage-specific protein expression in the parasite life cycle. </plain></SENT>
</text></p><p><text><SENT sid="172" pm="."><plain>In the last few years, a new class of biological regulatory molecules has been defined with the discovery of small (∼22-nucleotide) RNA species which bind to and inhibit translation of target mRNAs and mediate their degradation within the cell. </plain></SENT>
<SENT sid="173" pm="."><plain>Most documented cases of miRNA binding are to the 3′ untranslated region (3′ UTR) downstream of the translational stop codon. </plain></SENT>
<SENT sid="174" pm="."><plain>Abundant miRNAs have been described in several nematode species (Chen et al., 2011; Poole et al., 2010; Winter et al., 2012), most notably the free-living worm C. elegans, which provides well-characterised conserved sequences such as let-7 (Ambros et al., 2003; Hammell et al., 2009). </plain></SENT>
<SENT sid="175" pm="."><plain>Although no miRNAs have yet been described in T. canis, it had been noted that 4 abundant novel transcript (ANT) genes from the larval stage shared highly similar 3′ UTR sequences despite dissimilar coding sequences (Tetteh et al., 1999). </plain></SENT>
<SENT sid="176" pm="."><plain>Interestingly, in the larval parasite, no evidence of proteins corresponding to the ANT genes was found, indicating that either gene transcription or mRNA translation was suppressed within the arrested stage. </plain></SENT>
<SENT sid="177" pm="."><plain>Within the 3′ UTR tracts of each transcript were motifs similar to those targeted in C. elegans by let-7, and when the 3′ UTR of a T. canis ANT gene was inserted downstream of a GFP construct in transgenic C. elegans, suppression of gene expression was achieved (Callister et al., 2008). </plain></SENT>
<SENT sid="178" pm="."><plain>Thus, although the involvement of canonical miRNA mechanisms in control of larval gene expression has yet to be directly demonstrated, these studies strongly suggest that this is the case. </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec id="sec0070"><label>11</label><title><text><SENT sid="179" pm="."><plain>Future prospects and priorities </plain></SENT>
</text></title><p><text><SENT sid="180" pm="."><plain>Expanding our understanding of immune recognition and evasion by T. canis is a priority if we are to appropriately manage both human and veterinary disease. </plain></SENT>
<SENT sid="181" pm="."><plain>Molecular studies to date have identified key products which are already being used in new diagnostic assays, and doubtless further refinement will lead to the replacement of native TES as the principal diagnostic reagent. </plain></SENT>
<SENT sid="182" pm="?"><plain>Beyond this very necessary innovation, two general and interrelated areas of research need to be addressed: by what molecular means does T. canis suppress host immunity, and how can we intervene to provide immunological protection in either or both the definitive and paratenic host? </plain></SENT>
<SENT sid="183" pm="."><plain>These questions should spotlight the highly evolved state of immune evasion by T. canis, with every probability of defining new immunomodulatory molecules. </plain></SENT>
<SENT sid="184" pm="."><plain>In this way, future work can pave the way for rational immunological tools, most importantly vaccines for use in canid species, to mimimise, if not altogether eradicate, this important infection. </plain></SENT>
</text></p></sec></SecTag><SecTag type="COMP_INT"><sec id="sec0075"><title><text><SENT sid="185" pm="."><plain>Conflict of interest </plain></SENT>
</text></title><p><text><SENT sid="186" pm="."><plain>None. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="bib0005"><text><SENT sid="187" pm="."><plain>Abo-ShehadaM.N.Al-ZubaidyB.A.HerbertI.V.Acquired immunity to Toxocara canis infection in miceVet. </plain></SENT>
<SENT sid="188" pm="."><plain>Parasitol.3819912892981882497 </plain></SENT>
</text></ref><ref id="bib0010"><text><SENT sid="189" pm="."><plain>AllenJ.E.MacDonaldA.S.Profound suppression of cellular proliferation mediated by the secretions of nematodesParasite Immunol.2019982412479651925 </plain></SENT>
</text></ref><ref id="bib0015"><text><SENT sid="190" pm="."><plain>AmbrosV.LeeR.C.LavanwayA.WilliamsP.T.JewellD.MicroRNAs and other tiny endogenous RNAs in C. elegansCurr. </plain></SENT>
<SENT sid="191" pm="."><plain>Biol.13200380781812747828 </plain></SENT>
</text></ref><ref id="bib0020"><text><SENT sid="192" pm="."><plain>AmerH.HofingerA.PuchbergerM.KosmaP.Synthesis of O-methylated disaccharides related to excretory/secretory antigens of Toxocara larvaeJ. </plain></SENT>
<SENT sid="193" pm="."><plain>Carbohydr. </plain></SENT>
<SENT sid="194" pm="."><plain>Chem.202001719731 </plain></SENT>
</text></ref><ref id="bib0025"><text><SENT sid="195" pm="."><plain>BadleyJ.E.GrieveR.B.RockeyJ.H.GlickmanL.T.Immune-mediated adherence of eosinophils to Toxocara canis infective larvae: the role of excretory–secretory antigensParasite Immunol.919871331433550601 </plain></SENT>
</text></ref><ref id="bib0030"><text><SENT sid="196" pm="."><plain>BadleyJ.E.GrieveR.B.BowmanD.D.GlickmanL.T.RockeyJ.H.Analysis of Toxocara canis larval excretory–secretory antigens: physicochemical characterization and antibody recognitionJ. </plain></SENT>
<SENT sid="197" pm="."><plain>Parasitol.7319875936003298601 </plain></SENT>
</text></ref><ref id="bib0035"><text><SENT sid="198" pm="."><plain>BeaverP.C.Toxocarosis (visceral larva migrans) in relation to tropical eosinophiliaBull. </plain></SENT>
<SENT sid="199" pm="."><plain>Soc. </plain></SENT>
<SENT sid="200" pm="."><plain>Pathol. </plain></SENT>
<SENT sid="201" pm="."><plain>Exot. </plain></SENT>
<SENT sid="202" pm="."><plain>Filiales55196255557613970019 </plain></SENT>
</text></ref><ref id="bib0040"><text><SENT sid="203" pm="."><plain>BeaverP.C.SnyderC.H.CarreraG.M.DentJ.H.LaffertyJ.W.Chronic eosinophilia due to visceral larva migransPediatrics9195271914911260 </plain></SENT>
</text></ref><ref id="bib0045"><text><SENT sid="204" pm="."><plain>BowmanD.D.OaksJ.A.GrieveR.B.Ultrastructure of the infective-stage larva of Toxocara canis (Werner, 1782) Stiles, 1905 (Nematoda: Ascaridoidea)J. </plain></SENT>
<SENT sid="205" pm="."><plain>Helm. </plain></SENT>
<SENT sid="206" pm="."><plain>Soc. </plain></SENT>
<SENT sid="207" pm="."><plain>Washington601993183204 </plain></SENT>
</text></ref><ref id="bib0050"><text><SENT sid="208" pm="."><plain>BoyceW.M.BranstetterB.A.KazacosK.R.Comparative analysis of larval excretory–secretory antigens of Baylisascaris procyonis, Toxocara canis and Ascaris suum by Western blotting and enzyme immunoassayInt. </plain></SENT>
<SENT sid="209" pm="."><plain>J. </plain></SENT>
<SENT sid="210" pm="."><plain>Parasitol.1819881091133366527 </plain></SENT>
</text></ref><ref id="bib0055"><text><SENT sid="211" pm="."><plain>BuijsJ.BorsboomG.RentingM.HilgersomW.J.van WieringenJ.C.JansenG.NeijensJ.Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school childrenEur. </plain></SENT>
<SENT sid="212" pm="."><plain>Respir. </plain></SENT>
<SENT sid="213" pm="."><plain>J.101997146714759230232 </plain></SENT>
</text></ref><ref id="bib0060"><text><SENT sid="214" pm="."><plain>BundyD.A.P.ThompsonD.E.RobertsonB.D.CooperE.S.Age relationships of Toxocara canis seropositivity and geohelminth infection prevalence in two communities in St. Lucia, West IndiesTrop. </plain></SENT>
<SENT sid="215" pm="."><plain>Med. </plain></SENT>
<SENT sid="216" pm="."><plain>Parasitol.3819873093123441737 </plain></SENT>
</text></ref><ref id="bib0065"><text><SENT sid="217" pm="."><plain>CallisterD.M.WinterA.D.PageA.P.MaizelsR.M.Four abundant novel transcript genes from Toxocara canis with unrelated coding sequences share untranslated region tracts implicated in the control of gene expressionMol. </plain></SENT>
<SENT sid="218" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="219" pm="."><plain>Parasitol.1622008607018703093 </plain></SENT>
</text></ref><ref id="bib0070"><text><SENT sid="220" pm="."><plain>CarvalhoE.A.A.RochaR.L.Toxocariasis: visceral larva migrans in childrenJ. </plain></SENT>
<SENT sid="221" pm="."><plain>Pediatr. </plain></SENT>
<SENT sid="222" pm="."><plain>(Rio J)87201110011021503372 </plain></SENT>
</text></ref><ref id="bib0075"><text><SENT sid="223" pm="."><plain>ChenM.X.AiL.XuM.J.ZhangR.L.ChenS.H.ZhangY.N.GuoJ.CaiY.C.TianL.G.ZhangL.L.ZhuX.Q.ChenJ.X.Angiostrongylus cantonensis: identification and characterization of microRNAs in male and female adultsExp. </plain></SENT>
<SENT sid="224" pm="."><plain>Parasitol.128201111612021356210 </plain></SENT>
</text></ref><ref id="bib0080"><text><SENT sid="225" pm="."><plain>ChristieJ.F.DunbarB.KennedyM.W.The ABA-1 allergen of the nematode Ascaris suum: epitope stability, mass spectrometry, and N-terminal sequence comparison with its homologue in Toxocara canisClin. </plain></SENT>
<SENT sid="226" pm="."><plain>Exp. </plain></SENT>
<SENT sid="227" pm="."><plain>Immunol.9219931251327682160 </plain></SENT>
</text></ref><ref id="bib0085"><text><SENT sid="228" pm="."><plain>CooperP.J.Toxocara canis infection: an important and neglected environmental risk factor for asthma?Clin. </plain></SENT>
<SENT sid="229" pm="."><plain>Exp. </plain></SENT>
<SENT sid="230" pm="."><plain>Allergy38200855155318241245 </plain></SENT>
</text></ref><ref id="bib0090"><text><SENT sid="231" pm="."><plain>De Andrade Lima CoêlhoR.De CarvalhoL.B.Jr.PerezE.P.ArakiK.TakeuchiT.ItoA.AokiT.YamasakiH.Prevalence of toxocariasis in northeastern Brazil based on serology using recombinant Toxocara canis antigenAm. </plain></SENT>
<SENT sid="232" pm="."><plain>J. </plain></SENT>
<SENT sid="233" pm="."><plain>Trop. </plain></SENT>
<SENT sid="234" pm="."><plain>Med. </plain></SENT>
<SENT sid="235" pm="."><plain>Hyg.72200510310715728875 </plain></SENT>
</text></ref><ref id="bib0095"><text><SENT sid="236" pm="."><plain>de SavignyD.H.In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnosis test for visceral larva migransJ. </plain></SENT>
<SENT sid="237" pm="."><plain>Parasitol.6119757817821165568 </plain></SENT>
</text></ref><ref id="bib0100"><text><SENT sid="238" pm="."><plain>de SavignyD.H.TizardI.R.Toxocaral larva migrans: the use of larval secretory antigens in haemagglutination and soluble antigen fluorescent antibody testsTrans. </plain></SENT>
<SENT sid="239" pm="."><plain>R. </plain></SENT>
<SENT sid="240" pm="."><plain>Soc. </plain></SENT>
<SENT sid="241" pm="."><plain>Trop. </plain></SENT>
<SENT sid="242" pm="."><plain>Med. </plain></SENT>
<SENT sid="243" pm="."><plain>Hyg.711977501507343311 </plain></SENT>
</text></ref><ref id="bib0105"><text><SENT sid="244" pm="."><plain>de SavignyD.H.VollerA.WoodruffA.W.Toxocariasis: serological diagnosis by enzyme immunoassayJ. </plain></SENT>
<SENT sid="245" pm="."><plain>Clin. </plain></SENT>
<SENT sid="246" pm="."><plain>Pathol.321979284288372253 </plain></SENT>
</text></ref><ref id="bib0110"><text><SENT sid="247" pm="."><plain>Del PreteG.De CarliM.MastromauroC.BiagiottiR.MacchiaD.FalagianiP.RicciM.RomagnaniS.Purified protein derivative of Mycobacterium tuberculosis and excretory–secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine productionJ. </plain></SENT>
<SENT sid="248" pm="."><plain>Clin. </plain></SENT>
<SENT sid="249" pm="."><plain>Invest.8819913463501829097 </plain></SENT>
</text></ref><ref id="bib0115"><text><SENT sid="250" pm="."><plain>DentL.A.DalyC.M.MayrhoferG.ZimmermanT.HallettA.BignoldL.P.CreaneyJ.ParsonsJ.C.Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canisInfect. </plain></SENT>
<SENT sid="251" pm="."><plain>Immun.6719999899939916122 </plain></SENT>
</text></ref><ref id="bib0120"><text><SENT sid="252" pm="."><plain>DespommierD.Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspectsClin. </plain></SENT>
<SENT sid="253" pm="."><plain>Microbiol. </plain></SENT>
<SENT sid="254" pm="."><plain>Rev.16200326527212692098 </plain></SENT>
</text></ref><ref id="bib0125"><text><SENT sid="255" pm="."><plain>DoedensA.LoukasA.MaizelsR.M.A cDNA encoding Tc-MUC-5, a mucin from Toxocara canis larvae identified by expression screeningActa Trop.79200121121711412804 </plain></SENT>
</text></ref><ref id="bib0130"><text><SENT sid="256" pm="."><plain>DoğanN.DinleyiciE.C.BorO.TözS.O.ÖzbelY.Seroepidemiological survey for Toxocara canis infection in the northwestern part of TurkeyTurkiye Parazitol. </plain></SENT>
<SENT sid="257" pm="."><plain>Derg.31200728829118224618 </plain></SENT>
</text></ref><ref id="bib0135"><text><SENT sid="258" pm="."><plain>ElefantG.R.ShimizuS.H.SanchezM.C.JacobC.M.FerreiraA.W.A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assayJ. </plain></SENT>
<SENT sid="259" pm="."><plain>Clin. </plain></SENT>
<SENT sid="260" pm="."><plain>Lab. </plain></SENT>
<SENT sid="261" pm="."><plain>Anal.20200616417216874812 </plain></SENT>
</text></ref><ref id="bib0140"><text><SENT sid="262" pm="."><plain>FalconeF.TettehK.K.A.HuntP.BlaxterM.L.LoukasA.C.MaizelsR.M.The new subfamily of cathepsin-Z-like protease genes includes Tc-cpz-1, a cysteine protease gene expressed in Toxocara canis adults and infective larvaeExp. </plain></SENT>
<SENT sid="263" pm="."><plain>Parasitol.94200020120710831387 </plain></SENT>
</text></ref><ref id="bib0145"><text><SENT sid="264" pm="."><plain>FallahM.AzimiA.TaherkhaniH.Seroprevalence of toxocariasis in children aged 1–9 years in western Islamic Republic of Iran, 2003East Mediterr. </plain></SENT>
<SENT sid="265" pm="."><plain>Health J.1320071073107718290400 </plain></SENT>
</text></ref><ref id="bib0150"><text><SENT sid="266" pm="."><plain>FattahD.I.MaizelsR.M.McLarenD.J.SpryC.J.F.Toxocara canis: interaction of human blood eosinophils with the infective larvaeExp. </plain></SENT>
<SENT sid="267" pm="."><plain>Parasitol.6119864214333709753 </plain></SENT>
</text></ref><ref id="bib0155"><text><SENT sid="268" pm="."><plain>GalvinT.J.Experimental Toxocara canis infections in chickens and pigeonsJ. </plain></SENT>
<SENT sid="269" pm="."><plain>Parasitol.50196412412714125154 </plain></SENT>
</text></ref><ref id="bib0160"><text><SENT sid="270" pm="."><plain>Gasser, R.B., 2013. </plain></SENT>
<SENT sid="271" pm="."><plain>A perfect time to harness advanced molecular technologies to explore the fundamental biology of Toxocara. </plain></SENT>
<SENT sid="272" pm="."><plain>Vet. </plain></SENT>
<SENT sid="273" pm="."><plain>Parasitol., <ext-link ext-link-type="doi" xlink:href="10.1016/j.vetpar.2012.12.031">http://dx.doi.org/10.1016/j.vetpar.2012.12.031</ext-link>, in press. </plain></SENT>
</text></ref><ref id="bib0165"><text><SENT sid="274" pm="."><plain>GemsD.H.FergusonC.J.RobertsonB.D.NievesR.PageA.P.BlaxterM.L.MaizelsR.M.An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26-kDa protein with homology to phosphatidylethanolamine-binding proteinsJ. </plain></SENT>
<SENT sid="275" pm="."><plain>Biol. </plain></SENT>
<SENT sid="276" pm="."><plain>Chem.270199518517185227629180 </plain></SENT>
</text></ref><ref id="bib0170"><text><SENT sid="277" pm="."><plain>GemsD.H.MaizelsR.M.An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteinsProc. </plain></SENT>
<SENT sid="278" pm="."><plain>Natl. </plain></SENT>
<SENT sid="279" pm="."><plain>Acad. </plain></SENT>
<SENT sid="280" pm="."><plain>Sci. </plain></SENT>
<SENT sid="281" pm="."><plain>U. </plain></SENT>
<SENT sid="282" pm="."><plain>S. </plain></SENT>
<SENT sid="283" pm="."><plain>A.931996166516708643687 </plain></SENT>
</text></ref><ref id="bib0175"><text><SENT sid="284" pm="."><plain>GiacominP.R.CavaM.TumesD.J.GauldA.D.IddawelaD.R.McCollS.R.ParsonsJ.C.GordonD.L.DentL.A.Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensisParasite Immunol.30200843544518507784 </plain></SENT>
</text></ref><ref id="bib0180"><text><SENT sid="285" pm="."><plain>GillespieS.H.BidwellD.VollerA.RobertsonB.D.MaizelsR.M.Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assayJ. </plain></SENT>
<SENT sid="286" pm="."><plain>Clin. </plain></SENT>
<SENT sid="287" pm="."><plain>Pathol.4619935515548331180 </plain></SENT>
</text></ref><ref id="bib0185"><text><SENT sid="288" pm="."><plain>GoodB.HollandC.V.TaylorM.R.LarragyJ.MoriartyP.O’ReganM.Ocular toxocariasis in schoolchildrenClin. </plain></SENT>
<SENT sid="289" pm="."><plain>Infect. </plain></SENT>
<SENT sid="290" pm="."><plain>Dis.39200417317815307025 </plain></SENT>
</text></ref><ref id="bib0190"><text><SENT sid="291" pm="."><plain>GuptaA.K.PavriK.M.Alteration in immune response of mice with dual infection of Toxocara canis and Japanese encephalitis virusTrans. </plain></SENT>
<SENT sid="292" pm="."><plain>R. </plain></SENT>
<SENT sid="293" pm="."><plain>Soc. </plain></SENT>
<SENT sid="294" pm="."><plain>Trop. </plain></SENT>
<SENT sid="295" pm="."><plain>Med. </plain></SENT>
<SENT sid="296" pm="."><plain>Hyg.8119878358402835835 </plain></SENT>
</text></ref><ref id="bib0195"><text><SENT sid="297" pm="."><plain>HammellC.M.KarpX.AmbrosV.A feedback circuit involving let-7-family miRNAs and DAF-12 integrates environmental signals and developmental timing in Caenorhabditis elegansProc. </plain></SENT>
<SENT sid="298" pm="."><plain>Natl. </plain></SENT>
<SENT sid="299" pm="."><plain>Acad. </plain></SENT>
<SENT sid="300" pm="."><plain>Sci. </plain></SENT>
<SENT sid="301" pm="."><plain>U. </plain></SENT>
<SENT sid="302" pm="."><plain>S. </plain></SENT>
<SENT sid="303" pm="."><plain>A.1062009186681867319828440 </plain></SENT>
</text></ref><ref id="bib0200"><text><SENT sid="304" pm="."><plain>HayashiE.TudaJ.ImadaM.AkaoN.FujitaK.The high prevalence of asymptomatic Toxocara infection among schoolchildren in Manado, IndonesiaSoutheast Asian J. </plain></SENT>
<SENT sid="305" pm="."><plain>Trop. </plain></SENT>
<SENT sid="306" pm="."><plain>Med. </plain></SENT>
<SENT sid="307" pm="."><plain>Public Health3620051399140616610641 </plain></SENT>
</text></ref><ref id="bib0205"><text><SENT sid="308" pm="."><plain>HillI.R.DenhamD.A.ScholtzC.L.Toxocara canis larvae in the brain of a British childTrans. </plain></SENT>
<SENT sid="309" pm="."><plain>R. </plain></SENT>
<SENT sid="310" pm="."><plain>Soc. </plain></SENT>
<SENT sid="311" pm="."><plain>Trop. </plain></SENT>
<SENT sid="312" pm="."><plain>Med. </plain></SENT>
<SENT sid="313" pm="."><plain>Hyg.7919853513544035735 </plain></SENT>
</text></ref><ref id="bib0210"><text><SENT sid="314" pm="."><plain>HotezP.J.WilkinsP.P.Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance?PLoS Negl. </plain></SENT>
<SENT sid="315" pm="."><plain>Trop. </plain></SENT>
<SENT sid="316" pm="."><plain>Dis.32009e40019333373 </plain></SENT>
</text></ref><ref id="bib0215"><text><SENT sid="317" pm="."><plain>IzzatN.N.OlsonL.J.Resistance of mice to Toxocara canis: effect of prechallenge infections and injections of worm extractsCan. </plain></SENT>
<SENT sid="318" pm="."><plain>J. </plain></SENT>
<SENT sid="319" pm="."><plain>Zool.481970106310665471781 </plain></SENT>
</text></ref><ref id="bib0220"><text><SENT sid="320" pm="."><plain>JacquierP.GottsteinB.StingelinY.EckertJ.Immuno-diagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kitJ. </plain></SENT>
<SENT sid="321" pm="."><plain>Clin. </plain></SENT>
<SENT sid="322" pm="."><plain>Microbiol.291991183118351774303 </plain></SENT>
</text></ref><ref id="bib0225"><text><SENT sid="323" pm="."><plain>JaroszW.Mizgajska-WiktorH.KirwanP.KonarskiJ.RychlickiW.WawrzyniakG.Developmental age, physical fitness and Toxocara seroprevalence amongst lower-secondary students living in rural areas contaminated with Toxocara eggsParasitology1372010536319691865 </plain></SENT>
</text></ref><ref id="bib0230"><text><SENT sid="324" pm="."><plain>JexA.R.LiuS.LiB.YoungN.D.HallR.S.LiY.YangL.ZengN.XuX.XiongZ.ChenF.WuX.ZhangG.FangX.KangY.AndersonG.A.HarrisT.W.CampbellB.E.VlaminckJ.WangT.CantacessiC.SchwarzE.M.RanganathanS.GeldhofP.NejsumP.SternbergP.W.YangH.WangJ.GasserR.B.Ascaris suum draft genomeNature479201152953322031327 </plain></SENT>
</text></ref><ref id="bib0235"><text><SENT sid="325" pm="."><plain>JexA.R.WaeschenbachA.LittlewoodD.T.HuM.GasserR.B.The mitochondrial genome of Toxocara canisPLoS Negl. </plain></SENT>
<SENT sid="326" pm="."><plain>Trop. </plain></SENT>
<SENT sid="327" pm="."><plain>Dis.22008e27318682828 </plain></SENT>
</text></ref><ref id="bib0240"><text><SENT sid="328" pm="."><plain>JungingerJ.SchwittlickU.LemensieckF.NolteI.Hewicker-TrautweinM.Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogsVet. </plain></SENT>
<SENT sid="329" pm="."><plain>Res.4320122322440243 </plain></SENT>
</text></ref><ref id="bib0245"><text><SENT sid="330" pm="."><plain>KennedyM.W.MaizelsR.M.MeghjiM.YoungL.QureshiF.SmithH.V.Species-specific and common epitopes on the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvaeParasite Immunol.919874074202442693 </plain></SENT>
</text></ref><ref id="bib0250"><text><SENT sid="331" pm="."><plain>KhooK.-H.MaizelsR.M.PageA.P.TaylorG.W.RendellN.DellA.Characterisation of nematode glycoproteins: the major O-glycans of Toxocara excretory–secretory antigens are O-methylated trisaccharidesGlycobiology119911631711823159 </plain></SENT>
</text></ref><ref id="bib0255"><text><SENT sid="332" pm="."><plain>KhooK.-H.MorrisH.R.DellA.Structural characterisation of the major glycans of Toxocara canis ES antigensLewisJ.MaizelsR.M.Toxocara and Toxocariasis: Clinical, Epidemiological and Molecular Perspectives1993Institute of BiologyLondon133140 </plain></SENT>
</text></ref><ref id="bib0260"><text><SENT sid="333" pm="."><plain>KlionA.D.NutmanT.B.The role of eosinophils in host defense against helminth parasitesJ. </plain></SENT>
<SENT sid="334" pm="."><plain>Allergy Clin. </plain></SENT>
<SENT sid="335" pm="."><plain>Immunol.1132004303714713904 </plain></SENT>
</text></ref><ref id="bib0265"><text><SENT sid="336" pm="."><plain>KoizumiA.YamanoK.TsuchiyaT.SchweizerF.KiuchiF.HadaN.Synthesis, antigenicity against human sera and structure-activity relationships of carbohydrate moieties from Toxocara larvae and their analoguesMolecules1720129023904222847142 </plain></SENT>
</text></ref><ref id="bib0270"><text><SENT sid="337" pm="."><plain>KolbekováP.VětvičkaD.SvobodaJ.SkirnissonK.LeissováM.SyrůčekM.MarečkováH.KolářováL.Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNSParasitol. </plain></SENT>
<SENT sid="338" pm="."><plain>Res.10920111267127821537988 </plain></SENT>
</text></ref><ref id="bib0275"><text><SENT sid="339" pm="."><plain>KrauseM.HirshD.A trans-spliced leader sequence on actin mRNA in C. elegansCell4919877537613581169 </plain></SENT>
</text></ref><ref id="bib0280"><text><SENT sid="340" pm="."><plain>KurodaE.YoshidaY.En ShanB.YamashitaU.Suppression of macrophage interleukin-12 and tumour necrosis factor-alpha production in mice infected with Toxocara canisParasite Immunol.23200130531111412383 </plain></SENT>
</text></ref><ref id="bib0285"><text><SENT sid="341" pm="."><plain>LoukasA.SelzerP.M.MaizelsR.M.Characterisation of Tc-cpl-1, a cathepsin L-like cysteine protease from Toxocara canis infective larvaeMol. </plain></SENT>
<SENT sid="342" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="343" pm="."><plain>Parasitol.9219982752899657332 </plain></SENT>
</text></ref><ref id="bib0290"><text><SENT sid="344" pm="."><plain>LoukasA.C.DoedensA.HintzM.MaizelsR.M.Identification of a new C-type lectin, TES-70, secreted by infective larvae of Toxocara canis, which binds to host ligandsParasitology121200054555411128806 </plain></SENT>
</text></ref><ref id="bib0295"><text><SENT sid="345" pm="."><plain>LoukasA.C.HintzM.LinderD.ParkinsonJ.TettehK.K.A.MullinN.P.MaizelsR.M.A family of secreted mucins from the parasitic nematode Toxocara canis bear diverse mucin domains but share similar flanking six-cysteine repeat motifsJ. </plain></SENT>
<SENT sid="346" pm="."><plain>Biol. </plain></SENT>
<SENT sid="347" pm="."><plain>Chem.2752000396003960710950959 </plain></SENT>
</text></ref><ref id="bib0300"><text><SENT sid="348" pm="."><plain>LoukasA.C.HuntP.MaizelsR.M.Cloning and expression of an aquaporin-like gene from a parasitic nematodeMol. </plain></SENT>
<SENT sid="349" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="350" pm="."><plain>Parasitol.99199928729310340494 </plain></SENT>
</text></ref><ref id="bib0305"><text><SENT sid="351" pm="."><plain>LoukasA.C.MaizelsR.M.Cloning and characterization of a prohibitin gene from infective larvae of the parasitic nematode Toxocara canisDNA Seq.9199832332810524759 </plain></SENT>
</text></ref><ref id="bib0310"><text><SENT sid="352" pm="."><plain>LoukasA.C.MullinN.P.TettehK.K.A.MoensL.MaizelsR.M.A novel C-type lectin secreted by a tissue-dwelling parasitic nematodeCurr. </plain></SENT>
<SENT sid="353" pm="."><plain>Biol.9199982582810469567 </plain></SENT>
</text></ref><ref id="bib0315"><text><SENT sid="354" pm="."><plain>LuoZ.J.WangG.X.YangC.I.LuoC.H.ChengS.W.LiaoL.Detection of circulating antigens and antibodies in Toxocara canis infection among children in Chengdu, ChinaJ. </plain></SENT>
<SENT sid="355" pm="."><plain>Parasitol.85199925225610219304 </plain></SENT>
</text></ref><ref id="bib0320"><text><SENT sid="356" pm="."><plain>MagnavalJ.-F.FaufingueJ.-H.MorassinB.FabreR.Eosinophil cationic protein, specific IgE and IgG4 in human toxocariasisJ. </plain></SENT>
<SENT sid="357" pm="."><plain>Helminthol.80200641742317125552 </plain></SENT>
</text></ref><ref id="bib0325"><text><SENT sid="358" pm="."><plain>MagnavalJ.-F.MichaultA.CalonN.CharletJ.-P.Epidemiology of human toxocariasis in La RéunionTrans. </plain></SENT>
<SENT sid="359" pm="."><plain>R. </plain></SENT>
<SENT sid="360" pm="."><plain>Soc. </plain></SENT>
<SENT sid="361" pm="."><plain>Trop. </plain></SENT>
<SENT sid="362" pm="."><plain>Med. </plain></SENT>
<SENT sid="363" pm="."><plain>Hyg.8819945315337992328 </plain></SENT>
</text></ref><ref id="bib0330"><text><SENT sid="364" pm="."><plain>MagnavalJ.-F.FabreR.MaurièresP.CharletJ.P.de LarrardB.Application of the western blotting procedure for the immuno-diagnosis of human toxocariasisParasitol. </plain></SENT>
<SENT sid="365" pm="."><plain>Res.7719916977021805214 </plain></SENT>
</text></ref><ref id="bib0335"><text><SENT sid="366" pm="."><plain>MagnavalJ.-F.MalardL.MorassinB.FabreR.Immuno-diagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP for the measurement of specific anti-Toxocara IgEJ. </plain></SENT>
<SENT sid="367" pm="."><plain>Helminthol.76200233533912498639 </plain></SENT>
</text></ref><ref id="bib0340"><text><SENT sid="368" pm="."><plain>MaizelsR.M.Infections and allergy – helminths, hygiene and host immune regulationCurr. </plain></SENT>
<SENT sid="369" pm="."><plain>Opin. </plain></SENT>
<SENT sid="370" pm="."><plain>Immunol.17200565666116202576 </plain></SENT>
</text></ref><ref id="bib0345"><text><SENT sid="371" pm="."><plain>MaizelsR.M.BalicA.Resistance to helminth infection: the case for interleukin-5-dependent mechanismsJ. </plain></SENT>
<SENT sid="372" pm="."><plain>Infect. </plain></SENT>
<SENT sid="373" pm="."><plain>Dis.190200442742915243913 </plain></SENT>
</text></ref><ref id="bib0350"><text><SENT sid="374" pm="."><plain>MaizelsR.M.de SavignyD.OgilvieB.M.Characterization of surface and excretory–secretory antigens of Toxocara canis infective larvaeParasite Immunol.6198423376701003 </plain></SENT>
</text></ref><ref id="bib0355"><text><SENT sid="375" pm="."><plain>MaizelsR.M.KennedyM.W.MeghjiM.RobertsonB.D.SmithH.V.Shared carbohydrate epitopes on distinct surface and secreted antigens of the parasitic nematode Toxocara canisJ. </plain></SENT>
<SENT sid="376" pm="."><plain>Immunol.13919872072142438350 </plain></SENT>
</text></ref><ref id="bib0360"><text><SENT sid="377" pm="."><plain>MaizelsR.M.SartonoE.KurniawanA.SelkirkM.E.PartonoF.YazdanbakhshM.T cell activation and the balance of antibody isotypes in human lymphatic filariasisParasitol. </plain></SENT>
<SENT sid="378" pm="."><plain>Today111995505615275373 </plain></SENT>
</text></ref><ref id="bib0365"><text><SENT sid="379" pm="."><plain>MaizelsR.M.TettehK.K.A.LoukasA.C.Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematodeInt. </plain></SENT>
<SENT sid="380" pm="."><plain>J. </plain></SENT>
<SENT sid="381" pm="."><plain>Parasitol.30200049550810731572 </plain></SENT>
</text></ref><ref id="bib0370"><text><SENT sid="382" pm="."><plain>MatsumuraK.KazutaY.EndoR.TanakaK.Detection of circulating toxocaral antigens in dogs by sandwich enzyme-immunoassayImmunology5119846096136365746 </plain></SENT>
</text></ref><ref id="bib0375"><text><SENT sid="383" pm="."><plain>MeghjiM.MaizelsR.M.Biochemical properties of larval excretory–secretory glycoproteins of the parasitic nematode Toxocara canisMol. </plain></SENT>
<SENT sid="384" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="385" pm="."><plain>Parasitol.1819861551703515176 </plain></SENT>
</text></ref><ref id="bib0380"><text><SENT sid="386" pm="."><plain>MohamadS.AzmiN.C.NoordinR.Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120)J. </plain></SENT>
<SENT sid="387" pm="."><plain>Clin. </plain></SENT>
<SENT sid="388" pm="."><plain>Microbiol.4720091712171719369434 </plain></SENT>
</text></ref><ref id="bib0385"><text><SENT sid="389" pm="."><plain>NeillD.R.WongS.H.BellosiA.FlynnR.J.DalyM.LangfordT.K.A.BucksC.KaneC.M.FallonP.G.PannellR.JolinH.E.McKenzieA.N.J.Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature46420101367137020200518 </plain></SENT>
</text></ref><ref id="bib0390"><text><SENT sid="390" pm="."><plain>NoordinR.SmithH.V.MohamadS.MaizelsR.M.FongM.Y.Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosisActa Trop.932005576215589798 </plain></SENT>
</text></ref><ref id="bib0395"><text><SENT sid="391" pm="."><plain>ObwallerA.DuchêneM.BruhnH.SteipeB.TrippC.KraftD.WiedermannG.AuerH.AspöckH.Recombinant dissection of myosin heavy chain of Toxocara canis shows strong clustering of antigenic regionsParasitol. </plain></SENT>
<SENT sid="392" pm="."><plain>Res.87200138338911403381 </plain></SENT>
</text></ref><ref id="bib0400"><text><SENT sid="393" pm="."><plain>ObwallerA.Jensen-JarolimE.AuerH.HuberA.KraftD.AspöckH.Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexesParasite Immunol.2019983113179717192 </plain></SENT>
</text></ref><ref id="bib0405"><text><SENT sid="394" pm="."><plain>OthmanA.A.Therapeutic battle against larval toxocariasis: are we still far behind?Acta Trop.124201217117822921951 </plain></SENT>
</text></ref><ref id="bib0410"><text><SENT sid="395" pm="."><plain>OthmanA.A.El-ShourbagyS.H.SolimanR.H.Kinetics of Foxp3-expressing regulatory cells in experimental Toxocara canis infectionExp. </plain></SENT>
<SENT sid="396" pm="."><plain>Parasitol.127201145445920974133 </plain></SENT>
</text></ref><ref id="bib0415"><text><SENT sid="397" pm="."><plain>PageA.P.HamiltonA.J.MaizelsR.M.Toxocara canis: monoclonal antibodies to carbohydrate epitopes of secreted (TES) antigens localize to different secretion-related structures in infective larvaeExp. </plain></SENT>
<SENT sid="398" pm="."><plain>Parasitol.75199256711379195 </plain></SENT>
</text></ref><ref id="bib0420"><text><SENT sid="399" pm="."><plain>PageA.P.MaizelsR.M.Bioynthesis and glycosylation of serine/threonine-rich secreted proteins from Toxocara canis larvaeParasitology10519922973081454427 </plain></SENT>
</text></ref><ref id="bib0425"><text><SENT sid="400" pm="."><plain>PageA.P.RichardsD.T.LewisJ.W.OmarH.M.MaizelsR.M.Comparison of isolates and species of Toxocara and Toxascaris by biosynthetic labelling of somatic and ES proteins from infective larvaeParasitology10319914514641780182 </plain></SENT>
</text></ref><ref id="bib0430"><text><SENT sid="401" pm="."><plain>PageA.P.RudinW.FluriE.BlaxterM.L.MaizelsR.M.Toxocara canis: a labile antigenic surface coat overlying the epicuticle of infective larvaeExp. </plain></SENT>
<SENT sid="402" pm="."><plain>Parasitol.75199272861639165 </plain></SENT>
</text></ref><ref id="bib0435"><text><SENT sid="403" pm="."><plain>PageA.P.RudinW.MaizelsR.M.Lectin binding to secretory structures, the cuticle and the surface coat of Toxocara canis infective larvaeParasitology10519922852961454426 </plain></SENT>
</text></ref><ref id="bib0440"><text><SENT sid="404" pm="."><plain>ParsonsJ.C.BowmanD.D.GrieveR.B.Tissue localization of excretory–secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasisAm. </plain></SENT>
<SENT sid="405" pm="."><plain>J. </plain></SENT>
<SENT sid="406" pm="."><plain>Trop. </plain></SENT>
<SENT sid="407" pm="."><plain>Med. </plain></SENT>
<SENT sid="408" pm="."><plain>Hyg.3519869749813532850 </plain></SENT>
</text></ref><ref id="bib0445"><text><SENT sid="409" pm="."><plain>PinelliE.AranzamendiC.Toxocara infection and its association with allergic manifestationsEndocr. </plain></SENT>
<SENT sid="410" pm="."><plain>Metab. </plain></SENT>
<SENT sid="411" pm="."><plain>Immune Disord. </plain></SENT>
<SENT sid="412" pm="."><plain>Drug Targets122012334422214330 </plain></SENT>
</text></ref><ref id="bib0450"><text><SENT sid="413" pm="."><plain>PinelliE.BrandesS.DormansJ.GremmerE.van LoverenH.Infection with the roundworm Toxocara canis leads to exacerbation of experimental allergic airway inflammationClin. </plain></SENT>
<SENT sid="414" pm="."><plain>Exp. </plain></SENT>
<SENT sid="415" pm="."><plain>Allergy38200864965818167123 </plain></SENT>
</text></ref><ref id="bib0455"><text><SENT sid="416" pm="."><plain>PinelliE.WithagenC.FonvilleM.VerlaanA.DormansJ.van LoverenH.NicollG.MaizelsR.M.van der GiessenJ.Persistent airway hyper-responsiveness and inflammation in Toxocara canis infected BALB/c miceClin. </plain></SENT>
<SENT sid="417" pm="."><plain>Exp. </plain></SENT>
<SENT sid="418" pm="."><plain>Allerg.352005826832 </plain></SENT>
</text></ref><ref id="bib0460"><text><SENT sid="419" pm="."><plain>PooleC.B.DavisP.J.JinJ.McReynoldsL.A.Cloning and bioinformatic identification of small RNAs in the filarial nematode, Brugia malayiMol. </plain></SENT>
<SENT sid="420" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="421" pm="."><plain>Parasitol.1692010879419874857 </plain></SENT>
</text></ref><ref id="bib0465"><text><SENT sid="422" pm="."><plain>QuattrocchiG.NicolettiA.MarinB.BrunoE.Druet-CabanacM.PreuxP.M.Toxocariasis and epilepsy: systematic review and meta-analysisPLoS Negl. </plain></SENT>
<SENT sid="423" pm="."><plain>Trop. </plain></SENT>
<SENT sid="424" pm="."><plain>Dis.62012e177522905274 </plain></SENT>
</text></ref><ref id="bib0470"><text><SENT sid="425" pm="."><plain>RobertsonB.D.BurkotT.R.GillespieS.H.KennedyM.W.WambaiZ.MaizelsR.M.Detection of circulating parasite antigen and specific antibody in Toxocara canis infectionsClin. </plain></SENT>
<SENT sid="426" pm="."><plain>Exp. </plain></SENT>
<SENT sid="427" pm="."><plain>Immunol.7419882362412465108 </plain></SENT>
</text></ref><ref id="bib0475"><text><SENT sid="428" pm="."><plain>Rubinsky-ElefantG.da Silva-NunesM.MalafronteR.S.MunizP.T.FerreiraM.U.Human toxocariasis in rural Brazilian Amazonia: seroprevalence, risk factors, and spatial distributionAm. </plain></SENT>
<SENT sid="429" pm="."><plain>J. </plain></SENT>
<SENT sid="430" pm="."><plain>Trop. </plain></SENT>
<SENT sid="431" pm="."><plain>Med. </plain></SENT>
<SENT sid="432" pm="."><plain>Hyg.792008939818606770 </plain></SENT>
</text></ref><ref id="bib0480"><text><SENT sid="433" pm="."><plain>Rubinsky-ElefantG.HirataC.E.YamamotoJ.H.FerreiraM.U.Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular formsAnn. </plain></SENT>
<SENT sid="434" pm="."><plain>Trop. </plain></SENT>
<SENT sid="435" pm="."><plain>Med. </plain></SENT>
<SENT sid="436" pm="."><plain>Parasitol.104201032320149289 </plain></SENT>
</text></ref><ref id="bib0485"><text><SENT sid="437" pm="."><plain>SchabussovaI.AmerH.van DieI.KosmaP.MaizelsR.M.O-Methylated glycans from Toxocara are specific targets for antibody binding in human and animal infectionsInt. </plain></SENT>
<SENT sid="438" pm="."><plain>J. </plain></SENT>
<SENT sid="439" pm="."><plain>Parasitol.3720079710917087964 </plain></SENT>
</text></ref><ref id="bib0490"><text><SENT sid="440" pm="."><plain>SchantzP.M.Toxocara larva migrans nowAm. </plain></SENT>
<SENT sid="441" pm="."><plain>J. </plain></SENT>
<SENT sid="442" pm="."><plain>Trop. </plain></SENT>
<SENT sid="443" pm="."><plain>Med. </plain></SENT>
<SENT sid="444" pm="."><plain>Hyg.41Suppl.198921342679161 </plain></SENT>
</text></ref><ref id="bib0495"><text><SENT sid="445" pm="."><plain>SchniederT.LaabsE.M.WelzC.Larval development of Toxocara canis in dogsVet. </plain></SENT>
<SENT sid="446" pm="."><plain>Parasitol.175201119320621095061 </plain></SENT>
</text></ref><ref id="bib0500"><text><SENT sid="447" pm="?"><plain>SmithH.HollandC.TaylorM.MagnavalJ.-F.SchantzP.MaizelsR.M.How common is human toxocariasis? </plain></SENT>
<SENT sid="448" pm="."><plain>Towards standardising our knowledgeTrends. </plain></SENT>
<SENT sid="449" pm="."><plain>Parasitol25200918218819269251 </plain></SENT>
</text></ref><ref id="bib0505"><text><SENT sid="450" pm="."><plain>SmithH.V.Antibody reactivity in human toxocariasisLewisJ.MaizelsR.M.Toxocara and Toxocariasis: Clinical, Epidemiological and Molecular Perspectives1993Institute of BiologyLondon91109 </plain></SENT>
</text></ref><ref id="bib0510"><text><SENT sid="451" pm="."><plain>SmithH.V.GirdwoodR.W.A.KuselJ.R.Misinterpretation of toxocaral serodiagnostic testsBr. </plain></SENT>
<SENT sid="452" pm="."><plain>Med. </plain></SENT>
<SENT sid="453" pm="."><plain>J.288198412356424806 </plain></SENT>
</text></ref><ref id="bib0515"><text><SENT sid="454" pm="."><plain>SmithH.V.KuselJ.R.GirdwoodR.W.A.The production of human A and B blood group like substances by in vitro maintained second stage Toxocara canis larvae: their presence on the outer larval surfaces and in their excretions/secretionsClin. </plain></SENT>
<SENT sid="455" pm="."><plain>Exp. </plain></SENT>
<SENT sid="456" pm="."><plain>Immunol.5419836256336360442 </plain></SENT>
</text></ref><ref id="bib0520"><text><SENT sid="457" pm="."><plain>SmithH.V.QuinnR.KuselJ.R.GirdwoodR.W.A.The effect of temperature and antimetabolites on antibody binding to the outer surface of second stage Toxocara canis larvaeMol. </plain></SENT>
<SENT sid="458" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="459" pm="."><plain>Parasitol.419811831937329441 </plain></SENT>
</text></ref><ref id="bib0525"><text><SENT sid="460" pm="."><plain>SmithK.A.HarcusY.GarbiN.HämmerlingG.J.MacDonaldA.S.MaizelsR.M.Type 2 innate immunity in helminth infection is induced redundantly and acts autonomously following CD11c+ cell depletionInfect. </plain></SENT>
<SENT sid="461" pm="."><plain>Immun.8020123481348922851746 </plain></SENT>
</text></ref><ref id="bib0530"><text><SENT sid="462" pm="."><plain>Strube, C., Heuer, L., Janacek, E., 2013. Toxocara spp. infections in paratenic hosts. </plain></SENT>
<SENT sid="463" pm="."><plain>Vet. </plain></SENT>
<SENT sid="464" pm="."><plain>Parasitol., <ext-link ext-link-type="doi" xlink:href="10.1016/j.vetpar.2012.12.033">http://dx.doi.org/10.1016/j.vetpar.2012.12.033</ext-link>, in press. </plain></SENT>
</text></ref><ref id="bib0535"><text><SENT sid="465" pm="."><plain>SuganeK.HowellM.J.NicholasW.L.Biosynthetic labelling of the excretory and secretory antigens of Toxocara canis larvaeJ. </plain></SENT>
<SENT sid="466" pm="."><plain>Helminthol.5919851471514031454 </plain></SENT>
</text></ref><ref id="bib0540"><text><SENT sid="467" pm="."><plain>SuganeK.OshimaT.Induction of peripheral blood eosinophilia in mice by excretory and secretory antigen of Toxocara canis larvaeJ. </plain></SENT>
<SENT sid="468" pm="."><plain>Helminthol.5819841431476747257 </plain></SENT>
</text></ref><ref id="bib0545"><text><SENT sid="469" pm="."><plain>TakamotoM.KusamaY.TakatsuK.NariuchiH.SuganeK.Occurrence of interleukin-5 production by CD4−CD8− (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canisImmunology8519952852917642218 </plain></SENT>
</text></ref><ref id="bib0550"><text><SENT sid="470" pm="."><plain>TakamotoM.OvingtonK.S.BehmC.A.SuganeK.YoungI.G.MatthaeiK.I.Eosinophilia, parasite burden and lung damage in Toxocara canis infection in C57Bl/6 mice genetically deficient in IL-5Immunology9019975115179176103 </plain></SENT>
</text></ref><ref id="bib0555"><text><SENT sid="471" pm="."><plain>TakamotoM.WangZ.X.WatanabeN.MatsuzawaA.NariuchiH.SuganeK.Eosinophilia, IgE production, and cytokine production by lung T cells in surface CD4-deficient mutant mice infected with Toxocara canisImmunology951998971049767463 </plain></SENT>
</text></ref><ref id="bib0560"><text><SENT sid="472" pm="."><plain>TaylorM.D.HarrisA.BabayanS.BainO.CulshawA.AllenJ.E.MaizelsR.M.CTLA-4 and CD4+CD25+ regulatory T cells inhibit protective immunity to filarial parasites in vivoJ. </plain></SENT>
<SENT sid="473" pm="."><plain>Immunol.17920074626463417878360 </plain></SENT>
</text></ref><ref id="bib0565"><text><SENT sid="474" pm="."><plain>TettehK.K.A.LoukasA.TrippC.MaizelsR.M.Identification of abundantly-expressed novel and conserved genes from infective larval stage of Toxocara canis by an expressed sequence tag strategyInfect. </plain></SENT>
<SENT sid="475" pm="."><plain>Immun.6719994771477910456930 </plain></SENT>
</text></ref><ref id="bib0570"><text><SENT sid="476" pm="."><plain>Van KnapenF.van LeusdenJ.PoldermanA.M.FranchimontJ.H.Visceral larva migrans: examination by means of enzyme-linked immunosorbent assay of human sera for antibodies to excretory–secretory antigens of the second-stage larvae of Toxocara canisZ. </plain></SENT>
<SENT sid="477" pm="."><plain>Parasitenkd.6919831131186837095 </plain></SENT>
</text></ref><ref id="bib0575"><text><SENT sid="478" pm="."><plain>WinterA.D.WeirW.HuntM.BerrimanM.GilleardJ.S.DevaneyE.BrittonC.Diversity in parasitic nematode genomes: the microRNAs of Brugia pahangi and Haemonchus contortus are largely novelBMC Genomics132012422216965 </plain></SENT>
</text></ref><ref id="bib0580"><text><SENT sid="479" pm="."><plain>Wiśniewska-LigierM.Woźniakowska-GesickaT.Sobolewska-DryjańskaJ.Markiewicz-JoźwiakA.WieczorekM.Analysis of the course and treatment of toxocariasis in children – a long-term observationParasitol. </plain></SENT>
<SENT sid="480" pm="."><plain>Res.11020122363237122205349 </plain></SENT>
</text></ref><ref id="bib0585"><text><SENT sid="481" pm="."><plain>WonK.Y.Kruszon-MoranD.SchantzP.M.JonesJ.L.National seroprevalence and risk factors for zoonotic Toxocara spp. infectionAm. </plain></SENT>
<SENT sid="482" pm="."><plain>J. </plain></SENT>
<SENT sid="483" pm="."><plain>Trop. </plain></SENT>
<SENT sid="484" pm="."><plain>Med. </plain></SENT>
<SENT sid="485" pm="."><plain>Hyg.79200855255718840743 </plain></SENT>
</text></ref><ref id="bib0590"><text><SENT sid="486" pm="."><plain>YamasakiH.ArakiK.LimP.K.ZasmyN.MakJ.W.TaibR.AokiT.Development of a highly specific recombinant Toxocara canis second-stage larva excretory–secretory antigen for immuno-diagnosis of human toxocariasisJ. </plain></SENT>
<SENT sid="487" pm="."><plain>Clin. </plain></SENT>
<SENT sid="488" pm="."><plain>Microbiol.3820001409141310747116 </plain></SENT>
</text></ref><ref id="bib0595"><text><SENT sid="489" pm="."><plain>YamasakiH.TaibR.WatanabeY.-i.MakJ.W.ZasmyN.ArakiK.ChooiL.P.K.KitaK.AokiT.Molecular characterization of a cDNA encoding an excretory–secretory antigen from Toxocara canis second stage larvae and its application to the immuno-diagnosis of human toxocariasisParasitol. </plain></SENT>
<SENT sid="490" pm="."><plain>Int.471998171181 </plain></SENT>
</text></ref><ref id="bib0600"><text><SENT sid="491" pm="."><plain>YariktasM.DemirciM.AynaliG.KayaS.DonerF.Relationship between Toxocara seropositivity and allergic rhinitisAm. </plain></SENT>
<SENT sid="492" pm="."><plain>J. </plain></SENT>
<SENT sid="493" pm="."><plain>Rhinol.21200724825017424889 </plain></SENT>
</text></ref><ref id="bib0605"><text><SENT sid="494" pm="."><plain>ZhouR.XiaQ.HuangH.LaiM.WangZ.Construction of a cDNA library from female adult of Toxocara canis, and analysis of EST and immune-related genes expressionsExp. </plain></SENT>
<SENT sid="495" pm="."><plain>Parasitol.129201112012621767535 </plain></SENT>
</text></ref></ref-list></SecTag><SecTag type="ACK_FUND"><ack><title>Acknowledgements</title><p><text4fund><text><SENT sid="496" pm="."><plain>Throughout this article I have referred extensively to the work of valued colleagues, in particular Brian Robertson, David Gems, Tony Page, Kevin Tetteh, Alex Loukas and Debbie Callister, all of whom I thank, and most of all the late Huw Smith who is very much missed by all of us. </plain></SENT>
</text></text4fund></p><p><text4fund><text><SENT sid="497" pm="."><plain>Funding: I gratefully acknowledge funding from the Wellcome Trust (Ref. </plain></SENT>
<SENT sid="498" pm="."><plain>090281). </plain></SENT>
</text></text4fund></p></ack></SecTag></back><floats-group><SecTag type="TABLE"><table-wrap id="tbl0005" position="float"><label>Table 1</label><caption><p><text><SENT sid="499" pm="."><plain>Defined proteins of Toxocara canis. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><text><SENT sid="500" pm="."><plain>Abbreviation </plain></SENT>
</text></th><th align="left"><text><SENT sid="501" pm="."><plain>Name </plain></SENT>
</text></th><th align="left"><text><SENT sid="502" pm="."><plain>TES component if applicable </plain></SENT>
</text></th><th align="left"><text><SENT sid="503" pm="."><plain>Accession number(s) </plain></SENT>
</text></th><th align="left"><text><SENT sid="504" pm="."><plain>Length (incl signal sequence if present) </plain></SENT>
</text></th><th align="left"><text><SENT sid="505" pm="."><plain>Notes </plain></SENT>
</text></th><th align="left"><text><SENT sid="506" pm="."><plain>Reference </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left"><text><SENT sid="507" pm="."><plain>Tc-ANT-3 </plain></SENT>
</text></td><td align="left"><text><SENT sid="508" pm="."><plain>Abundant novel transcript-3 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="509" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:EU792508">EU792508</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:ACF19852">ACF19852</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="510" pm="."><plain>271 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="511" pm="."><plain>Callister et al. (2008) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="512" pm="."><plain>Tc-ANT-5 </plain></SENT>
</text></td><td align="left"><text><SENT sid="513" pm="."><plain>Abundant novel transcript-5 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="514" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:EU792509">EU792509</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:ACF19853">ACF19853</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="515" pm="."><plain>489 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="516" pm="."><plain>Callister et al. (2008) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="517" pm="."><plain>Tc-ANT-30 </plain></SENT>
</text></td><td align="left"><text><SENT sid="518" pm="."><plain>Abundant novel transcript-30 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="519" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:EU792510">EU792510</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:ACF19854">ACF19854</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="520" pm="."><plain>843 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="521" pm="."><plain>Callister et al. (2008) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="522" pm="."><plain>Tc-ANT-34 </plain></SENT>
</text></td><td align="left"><text><SENT sid="523" pm="."><plain>Abundant novel transcript-34 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="524" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:EU792511">EU792511</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:ACF19855">ACF19855</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="525" pm="."><plain>608 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="526" pm="."><plain>Callister et al. (2008) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="527" pm="."><plain>Tc-AQP-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="528" pm="."><plain>Aquaporin </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="529" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAC32826">AAC32826</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="530" pm="."><plain>310 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="531" pm="."><plain>Loukas et al. (1999a) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="532" pm="."><plain>Tc-ARK-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="533" pm="."><plain>Arginine kinase </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="534" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:ABK76312">ABK76312</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AFJ95132">AFJ95132</ext-link> </plain></SENT>
</text></td><td/><td/><td align="left"><text><SENT sid="535" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="536" pm="."><plain>Tc-CPL-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="537" pm="."><plain>Cathepsin L-like cysteine protease </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="538" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAC48340">AAC48340</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="539" pm="."><plain>360 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="540" pm="."><plain>Loukas et al. (1998) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="541" pm="."><plain>Tc-CPZ-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="542" pm="."><plain>Cathepsin Z-like cysteine protease </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="543" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF143817">AF143817</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="544" pm="."><plain>307 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="545" pm="."><plain>Falcone et al. (2000) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="546" pm="."><plain>Tc-CTL-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="547" pm="."><plain>C-type lectin-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="548" pm="."><plain>TES-32 </plain></SENT>
</text></td><td align="left"><text><SENT sid="549" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF041023">AF041023</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="550" pm="."><plain>219 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="551" pm="."><plain>Binds mannose </plain></SENT>
</text></td><td align="left"><text><SENT sid="552" pm="."><plain>Loukas et al. (1999b) </plain></SENT>
</text></td></tr><tr><td/><td align="left"><text><SENT sid="553" pm="."><plain>Proteoglycan core protein </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="554" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AB009305">AB009305</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="555" pm="."><plain>219 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="556" pm="."><plain>Differs by 3 aa from above </plain></SENT>
</text></td><td align="left"><text><SENT sid="557" pm="."><plain>Yamasaki et al. (1998) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="558" pm="."><plain>Tc-CTL-2 </plain></SENT>
</text></td><td align="left"><text><SENT sid="559" pm="."><plain>C-type lectin-2 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="560" pm="."><plain>– </plain></SENT>
</text></td><td align="left"><text><SENT sid="561" pm="."><plain>219 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="562" pm="."><plain>17% aa divergence from CTL-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="563" pm="."><plain>Tetteh et al. (1999) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="564" pm="."><plain>Tc-CTL-3 </plain></SENT>
</text></td><td align="left"><text><SENT sid="565" pm="."><plain>C-type lectin-3 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="566" pm="."><plain>– </plain></SENT>
</text></td><td align="left"><text><SENT sid="567" pm="."><plain>220 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="568" pm="."><plain>13% aa divergence from CTL-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="569" pm="."><plain>Tetteh et al. (1999) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="570" pm="."><plain>Tc-CTL-4 </plain></SENT>
</text></td><td align="left"><text><SENT sid="571" pm="."><plain>C-type lectin-4 </plain></SENT>
</text></td><td align="left"><text><SENT sid="572" pm="."><plain>TES-70 </plain></SENT>
</text></td><td align="left"><text><SENT sid="573" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF126830">AF126830</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="574" pm="."><plain>288 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="575" pm="."><plain>Binds canine cell surface </plain></SENT>
</text></td><td align="left"><text><SENT sid="576" pm="."><plain>Loukas et al. (2000a) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="577" pm="."><plain>Tc-GLB-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="578" pm="."><plain>Pseudocoelomic globin </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="579" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAL56430">AAL56430</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AAL58703">AAL58703</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AAL58704">AAL58704</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="580" pm="."><plain>171 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="581" pm="."><plain>Minor sequence variants </plain></SENT>
</text></td><td align="left"><text><SENT sid="582" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="583" pm="."><plain>Tc-GLB-2 </plain></SENT>
</text></td><td align="left"><text><SENT sid="584" pm="."><plain>Intracellular globin </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="585" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAL56428">AAL56428</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AAL56429">AAL56429</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="586" pm="."><plain>153 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="587" pm="."><plain>∼50% identity to GLB-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="588" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="589" pm="."><plain>Tc-LDH-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="590" pm="."><plain>Lactate dehydrogenase </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="591" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAB07368">AAB07368</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="592" pm="."><plain>92 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="593" pm="."><plain>Partial sequence </plain></SENT>
</text></td><td align="left"><text><SENT sid="594" pm="."><plain>Unpubished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="595" pm="."><plain>Tc-MUC-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="596" pm="."><plain>Mucin-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="597" pm="."><plain>TES-120 </plain></SENT>
</text></td><td align="left"><text><SENT sid="598" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAB05820">AAB05820</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-n:U39815">U39815</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="599" pm="."><plain>176 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="600" pm="."><plain>15.7 kDa Serine-rich peptide backbone with 2 ShKT domains, 39.7 kDa total mass; 120 kDa apparent mobility on SDS-PAGE </plain></SENT>
</text></td><td align="left"><text><SENT sid="601" pm="."><plain>Gems and Maizels (1996) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="602" pm="."><plain>Tc-MUC-2 </plain></SENT>
</text></td><td align="left"><text><SENT sid="603" pm="."><plain>Mucin-2 </plain></SENT>
</text></td><td align="left"><text><SENT sid="604" pm="."><plain>TES-120 </plain></SENT>
</text></td><td align="left"><text><SENT sid="605" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF167707">AF167707</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="606" pm="."><plain>182 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="607" pm="."><plain>16.2 kDa peptide with 2 ShKT domains; 47.8 kDa total. </plain></SENT>
</text></td><td align="left"><text><SENT sid="608" pm="."><plain>Loukas et al. (2000b) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="609" pm="."><plain>Tc-MUC-3 </plain></SENT>
</text></td><td align="left"><text><SENT sid="610" pm="."><plain>Mucin-3 </plain></SENT>
</text></td><td align="left"><text><SENT sid="611" pm="."><plain>TES-120 </plain></SENT>
</text></td><td align="left"><text><SENT sid="612" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF167708">AF167708</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="613" pm="."><plain>269 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="614" pm="."><plain>26.0 kDa threonine-rich peptide with 4 ShKT domains, 45.0 kDa total. </plain></SENT>
</text></td><td align="left"><text><SENT sid="615" pm="."><plain>Loukas et al. (2000b) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="616" pm="."><plain>Tc-MUC-4 </plain></SENT>
</text></td><td align="left"><text><SENT sid="617" pm="."><plain>Mucin-4 </plain></SENT>
</text></td><td align="left"><text><SENT sid="618" pm="."><plain>TES-120 </plain></SENT>
</text></td><td align="left"><text><SENT sid="619" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF167709">AF167709</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="620" pm="."><plain>191 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="621" pm="."><plain>26.0 kDa threonine-rich peptide with 4 ShKT domains, 45.0 kDa total. </plain></SENT>
</text></td><td align="left"><text><SENT sid="622" pm="."><plain>Tetteh et al. (1999) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="623" pm="."><plain>Tc-MUC-5 </plain></SENT>
</text></td><td align="left"><text><SENT sid="624" pm="."><plain>Mucin-5 </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="625" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:AF167710">AF167710</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="626" pm="."><plain>316 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="627" pm="."><plain>26.0 kDa threonine-rich peptide with 4 ShKT domains, 45.0 kDa total. </plain></SENT>
</text></td><td align="left"><text><SENT sid="628" pm="."><plain>Doedens et al. (2001) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="629" pm="."><plain>Tc-MHC-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="630" pm="."><plain>Myosin heavy chain </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="631" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:CAC28360">CAC28360</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="632" pm="."><plain>1814 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="633" pm="."><plain>Obwaller et al. (2001) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="634" pm="."><plain>Tc-MLC-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="635" pm="."><plain>Myosin light chain </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="636" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-n:U25057">U25057</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="637" pm="."><plain>148 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="638" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="639" pm="."><plain>Tc-NPA-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="640" pm="."><plain>Nematode polyprotein </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="641" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:BAA14015">BAA14015</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AAD01628">AAD01628</ext-link>; <ext-link ext-link-type="uri" xlink:href="ncbi-p:AAB26196">AAB26196</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="642" pm="."><plain>140 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="643" pm="."><plain>Fragments of longer polyprotein </plain></SENT>
</text></td><td align="left"><text><SENT sid="644" pm="."><plain>Christie et al. (1993) and unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="645" pm="."><plain>Tc-PEB-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="646" pm="."><plain>Phosphatidylethanolamine-binding protein </plain></SENT>
</text></td><td align="left"><text><SENT sid="647" pm="."><plain>TES-26 </plain></SENT>
</text></td><td align="left"><text><SENT sid="648" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:P54190">P54190</ext-link>, <ext-link ext-link-type="uri" xlink:href="ncbi-n:U29761">U29761</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="649" pm="."><plain>262 aa </plain></SENT>
</text></td><td align="left"><text><SENT sid="650" pm="."><plain>PE-binding domain fused with 2 ShKT domains </plain></SENT>
</text></td><td align="left"><text><SENT sid="651" pm="."><plain>Gems et al. (1995) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="652" pm="."><plain>Tc-PRO-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="653" pm="."><plain>Prohibitin </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="654" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAB53231">AAB53231</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="655" pm="."><plain>274 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="656" pm="."><plain>Loukas and Maizels (1998) </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="657" pm="."><plain>Tc-SLO-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="658" pm="."><plain>Calcium activated channel </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="659" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:ACJ64718">ACJ64718</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="660" pm="."><plain>1123 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="661" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="662" pm="."><plain>Tc-SOD-1 </plain></SENT>
</text></td><td align="left"><text><SENT sid="663" pm="."><plain>Cu–Zn superoxide dismutase </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="664" pm="."><plain><ext-link ext-link-type="uri" xlink:href="ncbi-p:AAB00227">AAB00227</ext-link> </plain></SENT>
</text></td><td align="left"><text><SENT sid="665" pm="."><plain>190 aa </plain></SENT>
</text></td><td/><td align="left"><text><SENT sid="666" pm="."><plain>Unpublished </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><italic>Note</italic>: Gene abbreviations follow the convention of two-letter species abbreviation, a three-letter code for gene name (capitalised when referring to a protein product) and a number to distinguish related members of the same gene family.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
